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ABSTRACT 
 
Elevated expression of CKS2 protein has been detected in various types of cancer. Emerging 
evidence suggests that CKS2 affects cell cycle regulation through interactions with CDK1 and 
CDK2, and discovery of compounds that inhibit this interaction may be used to develop a novel 
cancer medicine. The aim of this thesis was to establish the yeast two hybrid (Y2H) system for 
detection of CKS2 interaction with CDK1, CDK2 and itself, using the URA3 reporter gene, as 
the system can be reversed and used to screen for compounds that dissociate the interactions. 
The HIS3 reporter gene was also used. The former two interactions have been detected with this 
reporter in a previous Y2H study. Versions of CDK1 and CDK2 that mimick the 
dephosphorylated, active state of the proteins were used. These proteins contained substitutions 
at amino acid 14 and 15, and are referred to as CDK1 AF and CDK2 AF. Primers were designed 
for use in cDNA amplification of CKS2, CDK1 AF and CDK2 AF by PCR. Each gene sequence 
was fused into the pENTR™/D-TOPO® vector, generating entry clones by a topoisomerase 
based cloning methodology. The gene sequences were transferred to the yeast expression vectors 
pDEST
TM
32 and pDEST
TM
22 in a site-specific recombination reaction. These vectors contained 
the CEN6/ARS4 sequence for replication which maintained low expression levels of the fusion 
protein. The expression vector constructs were verified through sequencing, and combinations of 
the constructs were transformed into S. cerevisiae MaV203. The CKS2 interactions were 
measured by plating onto specific media. Transcription of the HIS3 reporter gene was activated 
in the S. cerevisiae MaV203 cells when the interactions between CKS2 and the CDKs were 
investigated, providing further support to previous findings. Transcription of the URA3 reporter 
gene was, however, not activated, probably because the strength of the interactions was too low 
to be detected through URA3. An attempt to activate the URA3 reporter by using high copy-
number plasmids from a different system did not show activation of URA3 either. The CKS2-
CKS2 interaction was not detected either by use of the HIS3 or the URA3 reporter gene. Further 
work has to be performed in order to counteract the obstacles of URA3 activation. 
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INTRODUCTION 
 
Continuity of life depends on cells to proliferate, and the series of events allowing this is 
collectively called the cell cycle (1). The major components responsible of progression through 
the cell cycle are the cyclin-dependent kinases (CDKs). As the name indicates, cyclin binding is 
the primary determinant for their activity. Amongst other proteins shown to participate in the 
regulation of CDK activity, is the CDC28 protein kinase regulatory subunit 2 (CKS2) (2). The 
protein is assumed to affect the cell cycle progression through interactions with the CDKs, but its 
exact physiological role is yet to be determined (3;4). CKS2 proteins are also reported to interact 
with each other, forming a dimer (5;6). Upregulation of the CKS2 gene have been detected by 
analyses of cell material from patients with various types of cancer, in search for genes involved in 
progression of the disease (7-14). Tumors where high levels of this protein have been detected, 
include breast, cervical, prostate, gastric, bladder and hepatocellular carcinomas (8-12;14). A 
common feature associated with these high-level CKS2 tumors are poor response upon treatment 
and low survival probability of the patients. A novel therapeutic strategy may therefore be to 
inhibit the CKS2 binding to the CDKs. 
 
The yeast two-hybrid technology (Y2H) is the most widely used method to identify an interaction 
between two proteins (15). The method is based on the properties of the yeast GAL4 protein, 
which consists of two separable domains responsible for DNA-binding and transcriptional 
activation, respectively. By fusing two proteins to each of these domains, one can detect if the 
proteins interact by activation of one or more reporter genes, causing a phenotypic change of the 
recipient cell. An added advantage is that once the interaction is demonstrated in the Y2H system, 
the interaction can be screened against compounds that dissociate the undesirable interaction by 
reversing the original system (reverse Y2H) (16). The first step towards development of such a 
screen is confirmation of the interaction in the original system.  
 
The interaction of CKS2 to CDK1 and CDK2 was recently identified in our laboratory by 
activation of the HIS3 reporter gene in the Y2H system (17). cDNA of the genes were cloned into 
a high copy-number vector system, utilizing a high expression level of the proteins. The HIS3 
reporter gene is considered to be the most sensitive (18), and its use was therefore ideal in the 
establishment of the Y2H method.  The use of this reporter gene in a screen for compounds that 
dissociate protein bindings is however less advantageous, as disruption of binding will cause lack 
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of growth. Negative selection assays where disruption of reporter gene activation yields viable 
cells are more favorable, since yeast cells with no reporter activity can be selected from the plate 
for further analysis (16). One such reporter gene allowing negative selection is URA3. 
Identification of interactions through this reporter would enable the system to be reversed in 
search for inhibitors of the interactions (16). 
 
The aim of this thesis was to establish the Y2H system using the URA3 reporter gene, to explore 
whether the interactions between CKS2 and CDKs and between two CKS2 proteins could be 
detected in this system. It was also of interest to see whether previous studies showing the 
interactions could be confirmed, as the findings are not well established in the literature. Although 
detection of CKS2 dimers may not have any therapeutic potential at present, a method to inhibit 
this interaction could provide more insight into the function of CKS2. Furthermore, the HIS3 
reporter gene was used to increase the stringency of the analyses.  
 
The work included fusion of the CKS2 and CDK proteins to each domain of the GAL4 protein, 
using a recombinational cloning technique (19). Co-transformation of the fusion proteins in yeast, 
following growth on specific media was conducted to test for reporter activity of URA3 and HIS3. 
The expression vectors that were used utilized low expression levels of the fusion proteins. An 
attempt was also made to activate the URA3 reporter by using high copy-number plasmids. The 
physiological regulation of the CDKs includes inhibitory phosphorylations on threonine 14 and 
threonine 15 (20;21). To prevent the inactivation of the CDKs; mutated cDNA sequences of the 
CDKs simulating the dephosphorylated, active state were used. 
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1 BIOLOGICAL BACKGROUND                                               
 
1.1 The cell cycle 
The continuity of life depends on the ability of cells to reproduce (1;22). The series of events 
allowing duplication of the cells content and division into two daughter cells is collectively called 
the cell cycle. The cycle consists of four distinct phases separated in time, referred to as G1 (gap), 
S (synthesis), G2 (gap) and M (mitosis), where G1/S/G2 corresponds to interphase. Figure 1.1 is an 
illustration of the different phases of the cell cycle. During all of interphase, the cell duplicates its 
content and grows in mass. DNA is replicated in the S phase. In M phase, nuclear division 
(mitosis) followed by cytoplasmic division (cytokinesis) occur. There are also further subdivisions 
of the phases in mitosis; prophase, prometaphase, metaphase, anaphase and telophase. After 
mitosis, cells again enter G1, and repeat the cycle. Cells in G1 can also enter a specialized resting 
state called G0. It may stay in this state forever or for a short period of time (23). Cells in G0 can 
reenter the cycle if it receives the appropriate signals.  
 
 
Figure 1.1 The eukaryotic cell cycle. The cell cycle is comprised of four successive phases. G1 and G2 are gap 
phases where the cell grows in mass. S phase stands for synthesis, indicating the replication of DNA. In M phase, 
mitosis and cytokinesis occur. The cell can also enter a specialized resting state known as G0 (23). 
 
1.2 The cell cycle control system 
To ensure that each daughter cell is genetically identical to its mother cell, the onset and 
progression of each phase are under strict control (1;24). Serine/threonine protein kinases termed 
cyclin-dependent kinases (CDKs) are major components of this control system. These proteins are 
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activated at specific points of the cell cycle and make the decision to proceed, pause or exit the 
cell cycle.  
 
As the name indicates; the activity of CDKs are dependent on forming a complex with cyclins (1). 
Cyclins are regulatory protein subunits whose levels oscillate during the different phases of the 
cycle. The concentration of CDKs in the cell are constant, and the cyclins are in this way 
regulating kinase activity in a timely manner (25). When activated, the CDKs induce downstream 
processes by phosphorylating selected proteins, triggering the progress of the cell cycle if the 
internal and external environment is appropriate (25).  
 
1.2.1 The CDKs and their cyclin binding partners 
Four main CDKs; CDK1, CDK2, CDK4 and CDK6, and ten cyclins that belong to four different 
classes (the A, B, D and E-type cyclins) are involved in the cell cycle of human cells (23). In 
mammalian cells, cyclin complexes with CDK2, CDK4 and CDK6 have been implicated in the 
regulation of events during interphase, while CDK1 (also known as cell division control protein 2, 
cdc2) controls the initiation of mitosis (26). According to the classical model (figure 1.2), 
progression trough G1 phase is dependent on the activation of CDK4 and CDK6 by cyclin D. In 
late G1 phase, cyclin E associates with CDK2 which regulates progression into S phase and 
initiation of DNA replication (23). When the cell has entered S phase, a complex between 
cyclin A and CDK2 is formed and required throughout replication. In late G2 and early M phase, 
the CDK1/cyclin A complex promotes entry into M. Mitosis is further regulated by cyclin B in 
complex with CDK1.  
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Figure 1.2 The classical model of cell cycle regulation in the eukaryotic cell cycle. Cyclin complexes with CDK2, 
CDK4 and CDK6 have been implicated in the regulation of events during interphase, while CDK1 controls the 
initiation of mitosis. Compensatory mechanisms are however identified among the CDKs, and also among the 
different cyclins. Both positive and negative phosphorylations of the CDKs are also necessary for full activation of the 
complexes as described in section 1.3.2 (figure modified from (23)).  
 
Experiments with knockout mice have however revealed diverse compensatory mechanisms 
between the functions of the different CDK/cyclin complexes, challenging the classical model of 
cell cycle regulation (27-29). CDK1 has emerged as the master regulator of human cell cycle 
regulation, able to drive the progression through the different phases of the cell cycle alone, in 
complex with cyclins (27;29). Studies have shown that CDK1 compensates for depletion of 
CDK2, as CDK2
-/-
 mice are viable, but sterile. Deletion of CDK1 on the other hand, leads to early 
embryonic lethality. Similar studies were performed for CDK4 and CDK6, and also these have 
shown to play compensatory roles (30). Increasing evidence is therefore rejecting the theory that 
the CDKs and cyclins serve strictly determined phase-specific functions.  
 
1.2.2 Regulation of CDK activity   
The rise and fall of cyclin concentration is the primary determinant for CDK activity (1). Other 
mechanisms are however also important for fine-tuning CDK activity during the different phases 
of the cycle. These include both positive and negative regulatory phosphorylation of the CDKs 
(21), and the accumulation of CDK inhibitory proteins (23). To fully activate CDK1 and CDK2, 
phosphorylation at threonine 161 and 160, respectively, is required. This action is performed by a 
separate kinase, the CDK-activating kinase, CAK (25). Inhibitory phosphorylation on threonin 14 
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and tyrosin 15 by the kinases WEE1 and MYT1 leads to the inactivation of CDK1 and CDK2 
(21;31;32), whereas the dual-specificity phosphatase CDC25 counteracts this inactivation (33).  
 
Another important level of CDK regulation is specific inhibitors of CDK/cyclin complexes, called 
CDK inhibitors (CKI) (23;23;34). Two such families of CKI exist; the INK4 family and the 
Cip/Kip family. The INK4 family includes CDKN2A, CDKN2B, CDKN2C and CDKN2D, which 
inactivate CDK4 and CDK6 by forming stable complexes with the CDK enzyme, inhibiting 
binding with cyclin D (35). The activity of CDK1 and CDK2 are opposed by the second family; 
the Cip/Kip family (23). This family consists of CDKN1A, CDKN1B and CDKN1C.  
 
1.2.3 Checkpoints and mechanisms of cell cycle arrest  
The events of the cell cycle are at certain defined checkpoints monitored for abnormalities (23;36). 
DNA damage checkpoints are positioned in each of the gap phases before the cell enters S phase 
(G1/S checkpoint) and after DNA replication (G2/M checkpoint). There also appear to be DNA 
damage checkpoints during S and M phases and a spindle checkpoint (23), but these will not be 
discussed in this paper. 
 
Before the cell is committed to S phase, the DNA of the cell is closely examined for possible 
defects. If the DNA is found to be damaged, the progress through G1 will be delayed while 
mechanisms attempting to repair the damage are mobilized. The cell may also enter the resting 
state of G0 or even commit programmed cell death (apoptosis) if the damage is too severe and 
repair is not possible. This is referred to as the G1/S checkpoint of the cell cycle and prevents the 
replication of damaged DNA. The arrest is induced by the tumor suppressor gene TP53 (37). In its 
activated form, TP53 acts as a transcription factor that enhances the rate of transcription of genes 
that carry out effects arresting the cell cycle. For example, the transcription of the CDK-inhibitor 
CDKN1A is stimulated by TP53, which will inhibit the CDK2/cyclin E complex and thereby the 
initiation of replication. TP53 is also a major mediator for apoptosis (37).  
 
The mechanisms of the G2/M phase checkpoint does not allow the cell to enter mitosis if 
replication is incomplete or if DNA has damage to it (1;23). Although TP53 may play a role in 
this checkpoint, it is not dependent on it as the main mechanism for preventing entry into the 
M phase is activation of the ataxia telangiectasia mutated (ATM) kinase (23). ATM is responsible 
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for inhibiting the activity of CDC25, with the net results of also maintaining the CDK1/cyclin B 
complex in its inhibited form.  
 
1.2.4 Alteration of cell cycle regulators and cancer 
Defects in genes regulating the cell cycle are hallmarks of cancer cells (23). The main regulator of 
cell cycle arrest and apoptosis, TP53, has been subject to intense studies as it has become clear 
that it is the most frequently mutated gene in human cancer (37). Defects in other regulating 
molecules such as CDK inhibitors (CDKN2A, CDKN2B, CDKN2C, CDKN2D and CDKN1A) 
has also been implicated in tumor formation (24). The uncontrolled cell division and proliferation 
caused by such mutations, promotes tumor growth where the mutations are passed to their 
daughter cells (1). The cancerous cells can expand to surrounding tissue and dislodge from the 
tumor. These can further enter the blood circulation or lymphatic vessels and form secondary 
tumors in other organs (metastasis).  
 
1.3 CKS proteins 
In addition to the CDK-regulatory pathways described above, yet another group of proteins have 
shown to interact with the CDKs; the CDC28-protein kinase regulatory subunit (CKS proteins) 
(2). The detection of the human CKS proteins is derived from the identification of suc1 in fission 
yeast as a suppressor of mutations of the gene coding for CDK (38). Homologs in budding yeast 
(CKS1), frogs (Xe-p9) and humans (CKS1 and CKS2) have since then been identified (39-41). 
The human CKS proteins, CKS1 and CKS2, have 81 % identical gene sequence (41). Research 
with knockout mice suggests that these proteins share one or more functions as the depletion of 
either one have shown to not impact viability (42;43). CKS1
-/-
 mice are abnormally smaller than 
the wildtype, but has an otherwise normal phenotype (43). Mice nullozygous for CKS2 are 
associated with both male and female sterility (42). The sterility is thought to be due to an arrest of 
the germ cells in meiosis (42). On the other hand, depletion of both genes led to embryonic 
lethality (2). Collectively, these findings support the theory that the proteins are essential 
components of the cell cycle, although their precise function remains to be elucidated. 
 
A few studies have been performed to reveal the CKS proteins role in controlling CDK function. 
Overall, it appears that the CKS proteins do not act as inhibitors or activators of CDKs in the 
classic sense, but rather seem to modulate substrate choice or the extent of phosphorylation (4). It 
is now well recognized that the CKS proteins interact with CDKs by forming ternary complexes 
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containing a CDK, a cyclin, and a CKS protein (2;3;44;45). Egan and Solomon (3) showed that 
binding of CKS2 to CDK1 was stimulated in the presence of cyclin B. The binding was however 
highly dependent on the CDK1 phosphorylation at threonine 161, as binding was reduced with 
about 90 % in the absence of this phosphorylation. This association with CKS2 seemed to activate 
the dephosphorylation needed for passage through the G2/M checkpoint. They also investigated 
the binding of CKS2 to the CDK1/cyclin B complex with mutations in the gene sequence of the 
inhibitory phosphorylation sites, changing threonine 14 to alanine (T14A) and tyrosine 15 to 
phenylalanine (Y15F). Experiments where the mutations were tested individually (T14A and 
Y15F), or in combination (AF), showed that the dephosphorylated sites are only important for 
activation of CDKs, and not for binding of CKS2 (3). Interactions between CKS2 and CDK2 have 
also been detected (3;45;46). In which cyclin complex this occurs, is uncertain. The CKS2 binding 
to CDK1 and CDK2 has also been identified by the Y2H technique, using the HIS3 reporter gene 
(17). 
 
The CKS proteins have also been linked to induction of transcription of certain genes, such as 
cyclin A, cyclin B and CDK1 (2). They also appear to be essential in some destruction processes. 
Cyclin A, cyclin B, and CDKN1B have been shown to be degraded by the help of CKS proteins 
(43;47;48). Studies with Xenopus egg extracts suggests that the CKS proteins are required for 
optimal phosphorylation of certain CDK regulators; CDC25, CDC27; MYT1 and WEE1 (40;46). 
 
Characterization of the crystal structure of CKS2 has revealed that the protein can possess three 
different forms; as monomers, dimers or hexamers (5;6;49). The monomeric form is composed of 
four anti-parallel β strands and two α helices. The CKS proteins dimerize via an exchange of 
β strands between two monomers, a rather unusual interaction between proteins (4;5). Three 
strand-exchanged dimers can in turn form the ring-structured hexamer form (6). Bourne et al. (5) 
predicted trough molecular modelling that the CKS proteins would be unable to bind to a CDK in 
the form of a dimer because it was sterically hindered. Pines (50) suggests the possibility that 
there is an equilibrium of the monomer and dimer form in the cell, where only the monomer form 
is able to bind to the CDKs (figure 1.3) (5).  
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Figure 1.3  CKS2 protein interactions. The CKS2 protein is thought to be in equilibrium between the forms of 
monomers and dimers (three dimer molecules may also constitute the hexamer form, but this is not displayed in the 
figure). Only the monomer form is thought to bind to CDKs, where binding to CDK1 and CDK2 have been detected. 
Which cyclin CDK2 is in complex with when CKS2 binds is uncertain.  
 
1.3.1 CKS2 and cancer 
Despite their elusive physiological role, tumour profiling has revealed that both CKS1 and CKS2 
are frequently elevated in a variety of human cancers (7-14).  Furthermore, some studies associate 
especially CKS2 with aggressive disease and poor survival rates of the patients. In a study where 
gene expression profiling were used to predict clinical outcome of breast cancer, overexpression 
of CKS2 was associated with low survival (14). Lyng et al. (11) also identified the CKS2 gene as 
one amongst other genes associated with metastatic phenotypes of uterine cervical cancer, where 
high levels were associated with poor survival. To characterize the CKS proteins contribution to 
prostate tumorigenesis, a study performed by Lan et al. (10) revealed that elevated expression of 
CKS2 in prostate tumor cells protects the cell from apoptosis. Other carcinomas where elevated 
CKS2 is detected includes, gastric, bladder, nasopharyngeal, lymphoid and hepatocellular 
carcinoma (7-9;12;13).  
 
Although the link between elevated CKS2 proteins and their role in cancer development is yet to 
be determined, the studies above do indicate that CKS2 might be a contributing factor in 
cancerous cell proliferation. Since evidence points towards CKS2 exhibiting effects through 
binding with CDK1 and CDK2, a potential therapeutic strategy could therefore be inhibition of 
this interaction. Yeast two-hybrid (Y2H) technology is a method to detect an interaction between 
two proteins (51). An added advantage with this system is that it can be reversed (rY2H) and used 
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for identification of compounds inhibiting the interaction (52). The interactions of CKS2 with 
CDK1 and CDK2 have been shown to be robust enough to give expression of the HIS3 reporter in 
a Y2H system with high expression levels of the fusion proteins (17). In this thesis, the 
interactions of CKS2 with both CDK1 and CDK2 by expression of the URA3 and HIS3 reporters 
were investigated, in a system that yielded low expression levels of the fusion proteins. The 
interaction between two CKS2 molecules forming a dimer was also investigated. Figure 1.3 
displays the CKS2 interactions this project assessed.  
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2 METHODICAL BACKGROUND 
 
2.1  The yeast two-hybrid system 
All proteins interact with other molecules, and the biological properties of a protein depend on this 
physical interaction with other molecules (1). Signal transduction, enzymatic reactions, metabolic 
pathways and regulation are some examples of essential biological processes that require selective 
interactions between proteins (15;53). Many experimental techniques have been developed to 
study protein-protein interactions (54). Phage display, co-immunoprecipitation, cross-linking and 
the yeast two-hybrid (Y2H) system are some examples. The most frequently used method today is 
the Y2H system (15), a method originally developed by Fields and Song in 1989. It is an in vivo 
technique that takes advantage of the properties of the galactose-gene activating transcription 
factor (GAL4) of the yeast Saccharomyces cerevisiae (S. cerevisiae) (51). The GAL4 protein 
consists of two separable domains; the N-terminal domain and the C-terminal domain. The N-
terminal domain, also called DNA binding domain (BD or DBD), recognizes and binds to specific 
sequences in the DNA upstream of a promoter. These sequences are termed upstream activation 
sequences, or UAS. The C-terminal domain (activating domain, AD) stimulates transcription by 
binding of RNA polymerase. By fusing a protein to each of these domains, one can detect if two 
proteins interact by transformation into S. cerevisiae. Provided the two proteins that are fused to 
the two separable domains interact, the reconstituted GAL4 protein activates transcription of one 
or more reporter genes that enable a color reaction or growth on specific media. The protein X that 
is fused to the BD of GAL4 is termed the ‘bait’, whilst the second protein, Y, fused to the AD of 
GAL4 is termed the ‘prey’ (Fig. 2.1) (51;55).  
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Figure 2.1 The classical yeast two hybrid system. A protein of interest is fused to the DNA-binding domain (DBD), 
and this construct is called bait. Another protein is fused to the transcriptional activation domain (AD) and is called 
prey. The bait and prey is co-transformed into the yeast S. cerevisiae. The bait binds to the UAS of the promoter and if 
an interaction occurs between the bait and prey, AD is recruited and a functional transcription factor is reconstituted. 
This will lead to the recruitment of RNA polymerase and subsequent transcription of a reporter gene, generating a 
phenotypic signal (figure modified from (56)). 
 
 
Interactions between proteins in the Y2H system are scored by testing for expression of reporter 
genes. Fields and Song introduced the bait and prey into an S. cerevisiae strain harboring the lacZ 
reporter gene fused to the GAL1 promotor (51). Neither the bait nor the prey was able to activate 
the reporter gene when expressed isolated from each other. However, when they were co-
expressed, transcription of lacZ resulted in production of the enzyme beta-galactosidase, detected 
by the formation of blue yeast colonies on medium containing 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal) (51). This colorimetric reaction with the lacZ gene is still used, but 
other commonly used reporter genes in Y2H nowadays are auxotropic growth markers (52;57).  
Examples of such are the HIS3, ADE2, LEU2 and URA3 genes, which transcribe enzymes that 
participate in the synthesis of specific nutrients. Activation is therefore detected by growth on 
minimal media lacking the nutrients the enzymes provide.  
 
2.1.1 The HIS3 reporter gene 
An interaction between two proteins can be detected by activation of the HIS3 reporter gene (57). 
This reporter is expressed from a GAL1 promotor, and activation leads to the transcription of the 
enzyme imidazole glycerol phosphate dehydratase. This enzyme is involved in the histidine 
biosynthesis pathway. Detection of interaction by the use of this reporter is therefore growth on 
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medium lacking this amino acid (figure 2.2). The HIS3 reporter is considered to be the most 
sensitive, but also the least selective, and is reported to be leaky in most yeast strains (18). This 
can possibly generate a large number of false positives. To adjust the stringency of the reporter, a 
histidine analogue, 3-amino-1,2,4-triazol (3-AT) is added in the media. 3-AT is a competitive 
inhibitor of the HIS3 reporter gene product and is usually required to reduce the level of 
background growth (58). 
    
Figure 2.2 Representation of activation of the HIS3 and URA3 reporter gene. The transformed yeast are plated 
onto medium that selects for the presence of both plasmids (synthetic complete -leu-trp), and are then screened for 
HIS3 and URA3 activity. 
(i) Detection of interaction by the use of the HIS3 reporter is growth on medium lacking histidine.  
(ii) The URA3 gene product (ODCase) is essential for uracil biosynthesis, and the cells will be able to grow 
on medium lacking uracil where an interaction occurs. ODCase also catalyze the transformation of 5-
FOA into a toxic compound, and subsequently the transformed yeast strain will die in 5-FOA-containing 
media (figure modified from (56)). 
 
2.1.2 The URA3 reporter gene 
Activation of the URA3 reporter will produce orotidine-5-monophosphate decarboxylase 
(ODCase), an enzyme involved in the biosynthesis of the base uracil (53;57;59). Detection 
strategy is similar to that of the HIS3 reporter; growth on medium where uracil is omitted (figure 
2.2). An added advantage with the URA3 reporter is that it also allows negative selection (59). In 
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addition to participate in the formation of uracil, the ODCase also catalyzes the conversion of 5-
fluoroorotic acid (5-FOA) into the toxic compound 5-fluorouracil, causing cell death. If an 
interaction causes activation of the URA3 reporter, the transformed yeast strain will subsequently 
die in 5-FOA-containing media. That attribute has also proven to be highly convenient for use in 
screens that search for inhibitors of an interaction (16;56). If an interaction is disrupted on a 5-
FOA containing media, it will yield viable yeast cells that can be selected from the plate. By 
analyzing these further it can be determined how the interaction was inhibited. The positive 
growth also indicates that the compound is not toxic for the cell, thereby raising its potential for 
possible therapeutic use. A protein interaction disrupted with the conventional reporter genes such 
as HIS3 are detected by lack of growth (56). To isolate the cells in which the interaction is 
abolished requires replica plating of the yeast on general maintenance media, in addition to media 
that test for reporter activity. Those yeast cells showing no reporter gene activity must then be 
recovered from the general maintenance plate, which makes it more time consuming.  
 
The URA3 reporter is expressed from a modified SPO13 promoter (16). This promoter has a 
strong upstream repressing sequence that tightly controls transcription, and only strong protein 
interactions induce this gene sufficiently to allow growth on plates lacking uracil (16;60).  
 
2.1.3 Advantages and limitations with the Y2H system 
The Y2H system offers a number of advantages over other technologies to detect protein 
interactions (56-58). The Y2H system is often more sensitive than many in vitro techniques, and 
may therefore be more suited for detection of weak or transient interactions (56). Proteins 
expressed using bacterial cells or in vitro systems often lack key post-translational modifications 
that could be important for some protein interactions. There is also a possibility that the proteins 
may not be stable or fold correctly in the buffer conditions used, thereby making detection 
difficult. The Y2H technique is also considered to be less time-consuming and more inexpensive 
compared to the more classical methodologies (58).  
 
Choice of reporter gene has a great impact on the outcome of the Y2H analysis as some reporter 
genes are inherently more sensitive than others (57). Altering expression levels of bait and prey 
proteins may increase sensitivity, and the traditionally used vectors in the Y2H utilize the 2µ 
origin of replication which maintain plasmids at high copy-number (15-30 copies per cell) (57;61). 
In some cases however, high levels of the proteins are toxic to the cells, thereby inhibiting growth 
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causing the interaction to escape detection (62). The abnormally high expression level of bait and 
prey by the use of high copy-number vectors may also force an interaction to happen generating a 
false positive (58). The use of centromere-based low copy-number vectors with reduced 
expression levels could provide a solution for the toxicity (57;61). These vectors contain the 
CEN6/ARS4 sequence for replication which maintains the vector at 1-4 copies per cell. A study 
performed by Durefee et al. (61) have also shown that low copy-number vectors may provide 
stronger interaction signals despite of the much lower expression. Another approach that has been 
shown to reduce toxicity is the use of plasmids with modified promotors driving low level 
expression of the fusion proteins (56). 
 
Unfortunately the most selective reporters tend to be the least sensitive (57). As increased 
expression levels not always correlate with increased detection; altering the number of GAL4 
binding sites in the promoter of the reporter gene can increase sensitivity directly.  
 
The use of a highly sensitive reporter gene tends to generate large numbers of false positives (57). 
Some fusion proteins may also themselves transcriptionally activate the reporter genes, leading to 
false results as there is in fact no interaction present (62). Another reason that may lead to false 
interactions can arise as the system relies on proteins localizing in the nucleus of the yeast, which 
may not correspond to their natural cellular environment (58). The different environment yeast 
and mammalian cells possess can also contribute to a false interaction, even though they share 
many similarities as both are eukaryotes (58;63). Proteins known to be ‘sticky’ or that do not fold 
correctly in the system can also display a false interaction (58).  
 
For the same reason as false positive can occur because the system relies on proteins localizing in 
the nucleus of the yeast cell, false negatives can appear (56). Although many current Y2H vectors 
encode signals to localize non-nuclear proteins into the nucleus, many proteins can carry stronger 
signals for localization other places in the cell or contain strongly hydrophobic domains (such as 
membrane proteins). The proteins may also adopt a different conformation when expressed as 
fusions (62). This may result in the true interaction is inhibited. Finally, transient interactions, or 
interactions dependent on for example phosporylation of one of the proteins before an interaction 
can occur, may also escape detection (58). A solution to this problem may be the use of modified 
proteins where the needed phosphorylation is present, retaining the affinity for the other protein 
(58). 
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In general, to reduce artificially occurring interactions more than one reporter gene should be used 
(56). The reporter genes should also possess different promoter structures. Swapping the two 
domains for the two fusion proteins can also eliminate some false interactions (62). To increase 
the stringency even further, a detected interaction should be confirmed with alternative techniques 
(54;58).  
 
The popularity of this method has led to numerous modifications. The technique has been adapted 
for systems detecting protein-nucleic acid interactions (the yeast one-hybrid system) and protein-
RNA interactions (the yeast three-hybrid system) (56;64). New plasmids and strains for the use in 
the traditional Y2H system are continuously being developed, and the system is also extended for 
use in other organisms than yeast cells such as bacterial and mammal cells (56;65).  
Other than its use for identification of interacting proteins, the system can also be reversed (rY2H) 
to screen small molecule libraries for potential inhibitors of a given protein interaction, as 
described above (16;58).  
 
2.1.4 Steps involved in Y2H analysis 
Different molecular biological methods must be performed to carry out the Y2H analysis.  Site-
specific recombinational cloning provide an efficient methodology for constructing the fusion 
plasmids (19;66), but other cloning techniques are also available. With the technique, entry clones 
are first constructed by fusing amplified cDNA of the gene sequences into a specific vector, 
generating entry clones. The gene sequences are further transferred into yeast expression vectors 
in a site-specific recombination reaction, generating bait and prey. Co-transformation of the bait 
and prey constructs into yeast are then performed, following a test for reporter activity on specific 
media. These steps are presented in figure 2.3. 
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Figure 2.3 Overview of the different steps in protein interaction analyses by the use of the Y2H technique. 
Amplification of the genes by PCR must initially be performed. Generation of entry clones, followed by a transfer of 
the gene sequences into expression vectors by a site-specific recombination reaction generates bait and prey 
constructs. These are transformed into yeast, followed by test of reporter gene activity by growth on selective plates. 
 
2.2 Amplification of genes by Polymerase Chain Reaction 
Similar to the replication process that occurs in human cells, a given nucleotide sequence can be 
amplified in vitro by the polymerase chain reaction (PCR) (1;67). If the aim of the PCR is to later 
introduce the amplified products into bacteria or yeast, the nucleotide sequence of human genes 
(mRNA) must be converted to complementary DNA (cDNA). This conversion is important 
because in humans, the mRNA produced after replication must facilitate different modification 
processes in order to be translated into a protein (1). Bacteria and yeast are however not able to 
perform these modifications when a mammalian RNA transcript is introduced in the cell. The 
main difference between cDNA to both RNA and DNA is that cDNA contains only the coding 
sequence for the selected gene. Converting the mRNA of the gene sequence to cDNA is therefore 
crucial when bacterial and yeast cells are used to express mammalian gene sequences. An enzyme 
called reverse transcriptase is used to synthesize cDNA from mRNA (1). cDNA is then used as 
template in the PCR. 
 
A typical amplification reaction includes target DNA, a thermostable DNA polymerase, a forward 
and reverse primer, deoxynucleotide triphosphates (dNTPs), reaction buffer and magnesium (68). 
This reaction mix is placed in a thermal cycler, an instrument that subjects the reaction to a series 
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of different temperatures for set amounts of time. The cycles in PCR consists of three steps; 
denaturation of the template, annealing of the primers to the single-stranded target sequences(s), 
and extension of the annealed primers by a DNA polymerase (67). The GC content is the primary 
determinant for which temperature double-stranded DNA denaturate. The higher the GC 
concentration, the higher temperature is required to separate the two DNA strands. Lengths of the 
DNA molecule determine the time needed for complete separation; the longer the DNA molecule, 
the longer time is needed. Typical temperatures are 93-95 °C (67). 
 
The temperature is reduced to approximately 40-60 °C in the annealing step. As DNA polymerase 
can only add a nucleotide onto a preexisting 3'-OH group, a primer to which it can add the first 
nucleotide is therefore needed. In this step the forward and reverse primers associate with the 
denatured DNA, flanking it to allow a DNA polymerase to initiate synthesis of a complimentary 
strand (1). The temperatures which are the optimal for the primers is critical for the overall 
efficiency of amplification (67). There are several strategies in how to calculate this temperature, 
but none of them are accurate for all primer lengths and sequences. Experimental determination of 
the optimal temperature through a gradient PCR prior to the main PCR will yield the best results. 
However, if this is not possible it is recommended to use temperatures 3-5 degrees below the 
lowest calculated melting temperature (Tm) of the pair of primers used (67). 
 
In the third step, the synthesis of new DNA begins as the reaction temperature is raised to the 
optimum for the DNA polymerase. This temperature is in the range of 68–72 °C for most 
thermostable DNA polymerases. Every cycle doubles the amount of DNA synthesized in the 
previous cycle, and the newly synthesized strands serve as templates for the next cycle (1;67). To 
yield sufficient DNA amplification, 20-30 cycles is usually required (68). 
 
2.2.1 Primer design 
A vital step in the overall success of a PCR experiment is the design of suitable primers (69). The 
aim is to obtain a balance between specificity and efficiency of amplification. Specificity is the 
frequency with which a mispriming event occurs, giving undesirable products. Efficiency is 
defined as giving a high amplification yield (69). To achieve this, some rules must be followed in 
the design of the primers (67-69). Typical primers are 18-30 nucleotides in length having 40-60 % 
GC content. The 3’ end should be G or C, and the calculated Tm should not differ by more than 
5 °C between the forward and reverse primers (67). Complementarity between the primer pair 
  - 21 - 
must also be avoided, as this can lead to synthesis and amplification of primer dimers. This 
reaction can compete for the DNA polymerase and the other components in the reaction mix, 
suppressing amplification of the target DNA (67). Computer programs are available that aid in the 
primer design (70). 
 
2.3 Plasmid vectors 
Plasmids are independent DNA molecules separated from a cell’s chromosomal DNA (1). 
These extrachromosomal DNAs occur naturally in bacteria, yeast and some higher eukaryotic 
cells, but are not essential for viability. They rather contain genes that are advantageous to the 
host, for example genes encoding resistances to toxic substances such as antibiotics (1;71). 
Plasmids have evolved a variety of mechanisms to partition plasmid molecules accurately to their 
daughter cells, and to maintain a stable copy-number in their host (72). The copy number of a 
plasmid is defined as the average number of plasmids per bacterial/yeast cell, or per chromosome 
under normal growth conditions. The plasmids contain a replication origin, which enable them to 
be self-replicating, independent of the cells chromosome. The fact that it is easier to manipulate, 
copy and purify recombinant DNA when it is maintained in a vector, separate from the bacterial 
chromosome, has led to their popularity for use in gene cloning (1;72). A fragment of DNA, called 
an insert, may be ligated into the plasmids and in this way be used to carry and transfer a gene into 
a recipient cell, such as a bacteria or a yeast cell. This introduction of plasmid DNA into a 
recipient cell is called transformation (72). 
 
2.3.1 Selectable properties of plasmid vectors 
Only a fraction of the host cells will acquire the plasmid after a transformation (73). Separating 
cells that carry the insert DNA from the majority of non-recombinants is required to ensure that 
only the correct product is obtained. The use of genes coding for a specific selectable property 
such as antibiotic resistance is common (72). Growing transformed bacteria on medium containing 
the antibiotic the vector has a resistance gene against, will allow growth only of bacterial colonies 
carrying the plasmid. This enables cells that have taken up the recombinant DNA to be easily 
identified. Another selection technique which is used to get rid of unwanted plasmid-bearing cells 
is the use of the lethal ccdB-gene (73;74). The ccdB gene is purified from the E. coli miniF 
plasmid. This plasmid encodes two proteins, CcdB and CcdA, where Ccd stands for control of cell 
death. The interplay of these two proteins promotes a stable maintenance of plasmids by killing 
daughter cells that have not inherited a miniF plasmid at cell division (75;76). The CcdB protein is 
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a potent cytotoxin, whereas the CcdA protein acts as an antidote preventing the actions of CcdB 
(77). This lethal effect of the ccdB gene makes it an efficient tool for positive selection in 
recombination reactions.  
 
2.4   Recombinational cloning  
Cloning genes into vectors has traditionally relied on restriction enzyme digestion and ligation 
(67). In recent years, an alternative cloning methodology that takes advantage of site-specific  
recombination has been developed (19). The principle behind this technique is based upon the 
enzymatic mechanisms where the bacterial virus, bacteriophage λ, recombines its own DNA into 
the host’s chromosome. This action is performed by a set of three different enzymes; Integrase 
(Int), Excisionase (Xis) and the E. coli Integration Host Factor (IHF). These enzymes recognizes 
and binds to specific attachment (att) sites on the hosts’ DNA, makes an incision and inserts the 
phages own DNA (78).  
 
As the recombination occurs at specific att sites, construction of vectors containing two such att 
sites each will cause a site-specific recombination between the att sites from one vector to another 
by performing a reaction with the two vectors and the Int, Xis and IHF enzymes (78). Because the 
transfer of DNA segments in the recombination reaction does not rely on a replicative step, 
alterations to the nucleotide sequence are not expected (78).  
 
2.4.1 Construction of entry clones 
The pENTR™/D-TOPO® vector containing the attachment sites attL1 and attL2 can be used to 
produce entry clones (figure 2.4) (79). A blunt end PCR product is inserted between these att sites 
by a topoisomerase based cloning method. The vector is linear and has a topoisomerase enzyme 
covalently bound to each 3’ end. It carries a kanamycin resistance gene that allows selection of 
plasmid in E. coli, and it replicates in E. coli from the pUC ori. 
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Figure 2.4 Features of the pENTR
TM
/D-TOPO
®
 vector (79). A topoisomerase enzyme is bound to each 3’end, 
allowing the gene of interest to be ligated between the two att sites. The kanamycin resistance gene allows selection in 
E. coli.  
 
Topoisomerase Ι enzyme is a vaccinia virus that specifically bind to double-stranded DNA at 
CCCTT sites on the 5’ end, cleaving the phosphodiester backbone in one strand (78;80;81). A 
covalent bond between the 5’ phosphate of the incised strand and a tyrosyl residue (Tyr-274) of 
topoisomerase will be formed. An overhang with the bases GTGG, will basepair with 3’- CACC 
blunt-end PCR products. The PCR product will be fused to the vector, flanked by the att-sites 
(figure 2.5).  
 
 
Figure 2.5 Topoisomerase based cloning. Topoisomerase is covalently bound at 3’ blunt CCCTT ends on the vector, 
making it linear. CACC blunt end PCR products will basepair with a GTGG overhang at the 5’ end, fusing the PCR 
product into the vector (79). 
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The plasmid vector and gene insert must be present at an appropriate molar ratio in the reaction, in 
order to obtain ‘correct’ clones (72). If the plasmid vector is present in a too high concentration, 
the reaction may generate an undesirable number of empty plasmids. If too low, the reaction may 
yield an excess of linear and circular homo-and heteropolymers of varying sizes, compositions and 
orientation. For this reason, the orientation of the insert must be validated by restriction analysis 
(72). 
 
2.4.2 Construction of expression vectors 
By performing a recombination reaction between the entry clone and a destination vector, an 
expression vector can be generated (figure 2.6). An enzyme mix with the three enzymes described 
above; Int, Xis and IHF (LR clonase II mix) will facilitate the transfer of the gene from the entry 
clone to the destination vector. The reaction is highly specific; the attL1 will recombine with 
attR1, and not attR2, maintaining the orientation of the sequence during the reaction (19). 
 
 
Figure 2.6 Recombination reaction generating expression constructs. The LR clonase II enzyme mix consists of 
the Int, Xis and IHF enzymes which catalyze the recombination of an entry clone with a destination vector to create an 
expression clone (66). 
 
As described in section 2.4, the segment between two att sites is ‘switched’ in a recombination 
reaction. Using a destination vector that contains the ccdB gene between its att sites, will replace 
the ccdB gene with the gene of interest when a recombination occurs with an entry clone. 
Theoretically only the successful recombinant clones will grow. Transforming the vectors into 
E. coli lacking the miniF plasmid (F
-
) will cause death of cells that has taken up the by-product 
molecules retaining the ccdB gene, or unreacted vectors carrying the gene. The two recombination 
sites, attR1 and attR2, flanking the ccdB gene are converted to attB sites following the 
recombination reaction.  
 
pDEST
TM
32 and pDEST
TM
22 (figure 2.7) are destination vectors from Invitrogen that can be used 
in a recombination reaction to generate expression vectors (66). pDEST
TM
32 carries the GAL4 
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DNA binding domain forming the bait, while pDEST
TM
22 generate the prey (carries the GAL4 
AD).  
 
 
 
 
 
 
 
 
 
Figure 2.7 Features of CEN-based Y2H destination vectors (66). pDEST
TM
32 contains the GAL4  DNA binding 
domain (DBD), while  pDEST
TM
22 carries the activation domain (AD) coding sequence (66). Both vectors contain the 
ARS/CEN origin that permits the maintenance of the plasmid in low copy. Both are also designed with the same 
ADH1 promotor for expression of the two hybrids. 
 
The bait plasmid carries a gentamicin resistance gene (Gm
R
) for maintenance in E. coli, and the 
LEU2 gene for selection in yeast. The prey plasmid on the other hand contains the ampicillin 
resistance gene for selection in E. coli, and the TRP1 nutritional marker for selection in yeast. The 
constitutive promoter ADH1 is featured in both vectors to drive medium-level expression of the 
fusion proteins in yeast, while the pUC origin permits high-copy replication and maintenance in 
E. coli.  Both vectors are also equipped with the ARS4/CEN6 sequence for low-copy number 
replication. The attachments sites, attR1 and attR2, is the bacteriophage λ-derived sequences that 
allow directional recombinational cloning. In between these sites both vectors contain the 
chloramphenicol and ccdB-gene that permits negative selection.  
 
2.5 Yeast strain and transformation  
The yeast strain used in an Y2H experiment must carry mutations on the genes the bait and prey 
vectors are markers for (57). Thus, a vector carrying the TRP1 yeast marker must be paired with a 
yeast strain that carries a trp1 mutation. It is also important that the markers are not used as 
reporter genes, because the same gene cannot be used to select for both the presence of the 
plasmid and the interaction.  
 
A simple and efficient method for introducing plasmid DNA into yeast is the lithium acetate 
method (82). Yeast cells grown on rich medium are harvested and treated with lithium acetate 
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(LiAc), polyethylene glycol (PEG) and single stranded carrier DNA (ss DNA) to induce uptake of 
the plasmid. Plasmid-bearing yeast cells are selected by growth on synthetic complete (SC) 
minimal medium lacking the nutritional marker the plasmid is coding for. 
 
2.6 Purification of plasmid DNA 
Many techniques to purify plasmids from bacteria have been developed (72). The alkaline lysis 
method is a simple and effective method where a strong anionic detergent at high pH destructs the 
cell wall of the bacterium (83). Chromosomal DNA and proteins denaturates, whereas the strands 
of closed circular plasmids are protected against denaturation because they do not break, and stay 
topologically intertwined. The denaturated chromosomal DNA, proteins and broken cell wall of 
the bacterium are precipitated from the solution during lysis. The plasmid is recovered from the 
supernatant. This procedure can be done in different scales dependent on the need of the 
experiment. Mini-preparations yields between 100 ng to 5 µg of DNA, depending on the copy 
number of plasmid. Midi-preparations are useful when larger amount of DNA is needed, as it can 
yield as much as 50 µg (72). 
 
2.7 Restriction nucleases 
Restriction nucleases are enzymes naturally occurring in bacteria for protection against viral 
infection, by degrading incoming DNA (1). Each nuclease recognizes a specific DNA sequence, 
and cut the double helix into fragments of strictly defined sizes. The bacterium’s own DNA is 
protected from this cleavage by modification of these sequences. Different restriction nucleases 
have different sequence specificities known as restriction sites, and a large number of restriction 
nucleases have been isolated from prokaryotic organisms and used in research (1). One application 
is verification of insertion of genes into vectors after a cloning reaction. The cut fragments can 
further be analyzed by separation with gel electrophoresis (72). 
 
2.8 Gel electrophoresis 
Gel electrophoresis is a technique to separate, purify and identify DNA fragments of different 
sizes (1;72). For DNA in the size range 300 to 10 000 bp, the most effective separation is done by 
the use of agarose gel (1). Agarose is a linear polymer composed of alternating residues of D- and 
L-galactose, forming a lattice the fragments must migrate through (72). Samples of DNA are 
loaded in wells at one end of the gel, and a voltage is applied across the gel. A buffer solution 
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covering the gel is leading the electricity. Because DNA is negatively charged, the fragments will 
migrate toward the positive electrode. Smaller fragments more easily migrate through the gel, as 
they do not get impeded by the agarose matrix (1). Other factors will also determine the rate of 
migration, such as the applied voltage, agarose concentration and the conformation of DNA. The 
conformation can be either superhelical circular, nicked circular and linear (84). Which 
conformation that migrate the fastest can vary greatly, depending on the present conditions; such 
as concentration and type of agarose, the ionic strength of the buffer and the electric field. Because 
of this, the best way to distinguish between the different conformational forms of DNA is to 
include a sample of untreated circular DNA in the gel, and a sample of the same DNA that has 
been linearized by digestion with a restriction enzyme that cleaves the DNA in only one place 
(72).  
 
Before samples are loaded into the gel, a loading buffer is added. The purpose of these buffers is 
to increase the density of the samples, assuring that the DNA sinks evenly in the well. The buffer 
will also add a color to the samples, simplifying the loading process. The dye also migrates 
through the gel in the same direction as DNA in predictable rates, to monitor the progress of the 
electrophoresis. For example, the dye bromophenol blue will migrate at a rate equivalent to 300 bp 
DNA in 0.5-1.4 % agarose gels (72). In order for the DNA to be visible, the gel is stained with a 
dye, such as GelRed, which fluoresces under ultraviolet light when it is bound to DNA (1). If 
necessary, these bands of DNA can be excised from the gel and used for a variety of purposes 
(72). 
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3 METHODS 
3.1 Experimental outline 
The flowchart in figure 3.1 illustrates the major steps in the experimental work of the thesis: 
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Figure 3.1 Illustration of the experimental work. Primers were designed for use in a PCR reaction to amplify 
cDNA of CDK2, CDK1 AF and CDK2 AF (step 1). The PCR products were fused into an att-site-containing entry 
vector by a topoisomerase based cloning method (step 2). The gene was then transferred from the entry vector into 
two different destination vectors (pDEST
TM
32 and pDEST
TM
22) by a site-specific recombination reaction between the 
att sites in step 3, generating expression constructs for bait and prey. These expression constructs were introduced into 
S. cerevisiae (step 4), and analyzed for interaction by plating onto selection plates (step 5). 
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3.2 Primer design and PCR (step 1) 
PCR were used to amplify cDNA of the genes CKS2, CDK1 and CDK2. The gene sequences were 
retrieved from the department of cell biology’s strain collection, present in pGBK-vectors 
transformed into XL10-Gold ultracompetent E. coli cells. CDK1 and CDK2 contained two 
mutations; amino acid 14 was changed from threonine to alanine, and amino acid 15 was replaced 
with phenylalanine instead of tyrosine. The purpose of these substitutions was to mimic the 
dephosphorylated, active state of the CDKs. CDK1 and CDK2 with these substitutions will from 
now on be referred to as CDK1 AF and CDK2 AF. 
 
The nucleotide sequences obtained from internet resources of the National Center for 
Biotechnology Information, NCBI (85) (appendix 16), were used in the design of forward and 
reverse primers for each gene. Primer lengths were between 19 and 27 nucleotides, and all 3’ends 
were a G or a C. The melting temperature (Tm) and GC-content were calculated by using the 
program OligoCalc (version 3.26) (70), where the Tm was in the range from 52.8 – 55.4 °C, while 
the GC content varied from 33-63 % for the six primers. An addition of 4 nucleotides, CACC, to 
the 5’ end of the forward primers were added to allow directional cloning in the pENTR™/D-
TOPO
®
 vector for creation of the entry clones (step 2 in figure 3.1). The nucleotide sequences for 
the designed primers are shown in appendix 1 (table 1), and they were purchased from Eurogentec 
S.A in Belgium. 
 
Before PCR was conducted, plasmid DNA (pGBK-gene) was purified from the E. coli cells by 
alkaline lysis of overnight cultures, in a process described in appendix 6 (miniprep). The 
procedure for making overnight cultures is described in appendix 5. 
 
3.2.1 Gradient PCR 
A gradient PCR was performed in order to experimentally determine the optimal primer annealing 
temperature. Using the gradient function of the Mastercycler
®
, a temperature gradient 
programmed between 45 °C to 65.6 °C were built up across the heating block, as the calculated 
temperature was in the range from 52.8 – 55.4 °C for the six primers. Reaction mixtures and 
cycling conditions are described in appendix 2a. Following the PCR, the samples were further 
subjected to a 1.5 % agarose gel for gel electrophoresis (appendix 3). The gel was stained with 
GelRed, and visualized and photographed under a UV transilluminator after electrophoresis. 
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3.2.2 Preparative PCR and agarose gel purification  
A preparative PCR was executed under the same setup and amounts as in the gradient PCR, but 
with the optimal primer annealing temperature. Each PCR reaction had a total reaction volume of 
100 μl, and the reaction mixes and cycling parameters are described in appendix 2b. 
 
Following the PCR, the samples were size fractioned on a 1.5 % agarose gel, according to the 
procedure described in appendix 3. Four teeth of the comb were taped up to form one large narrow 
well, and three such taped up sections were made, one for each gene. As CDK1 AF and CDK2 AF 
are of similar size (894 and 897 bp respectively), these genes were loaded at either side of CKS2, 
to avoid contamination into each other’ wells. After immersing the agarose gel in GelRed after the 
electrophoresis, the separated DNA fragments were visualized by UV detection and excised with a 
scalpel. The gel pieces were further purified using the Wizard
®
 SV Gel and PCR Clean-Up System 
from Promega, as described in appendix 4. 
 
3.3 Construction of entry clones (step 2) 
The gel purified PCR products were cloned into the entry vector, pENTR™/D-TOPO®, by 
topoisomerase-based molecular cloning (step 2 in figure 3.1). The pENTR™ Directional TOPO® 
Cloning Kits from Invitrogen was used for this purpose (appendix 10), where the blunt-end CACC 
of the PCR product base paired with the overhang sequence, GTGG, in the pENTR™/D-TOPO® 
vector. The reaction mixtures were transformed into One Shot chemically competent E. coli cells, 
and plated on Luria Bertani (LB) agar containing kanamycin to select for plasmid-bearing E. coli 
clones. The plates were incubated overnight at 37 °C. 
 
3.3.1 Restriction enzyme analysis of entry clones 
Restriction enzyme analysis was performed on randomly selected positive transformants from the 
cloning reaction to confirm the presence of the genes in the pENTR™/D-TOPO® vector. 
Transformants were cultured overnight in LB medium containing kanamycin (appendix 5), 
whereafter a glycerol stock were made (appendix 8), and the plasmid DNA was isolated by 
alkaline lysis (appendix 6).  
 
Restriction reactions containing the plasmid DNA to be analyzed, the restriction enzymes NotI HF 
and AscI, and an enzyme buffer mix were set up (appendix 14). After 2-4 hours of digestion, the 
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samples were further subjected to gel electrophoresis (appendix 3). The cut DNA fragments were 
visualized and photographed using GelRed under UV illumination.  
 
3.4 Construction of bait and prey plasmids (step 3) 
CKS2, CDK1 AF and CDK2 AF were transferred from the entry vector into two different 
destination vectors (pDEST
TM
32 and pDEST
TM
22) by a site-specific recombination reaction 
between the att sites in step 3, generating expression constructs for bait and prey. The vector 
generating the bait was pDEST
TM
32 and pDEST
TM
22 produced the preys, and maps for these 
vectors are described in appendix 12. The three genes were cloned both as bait and prey to 
investigate the interactions fused to both domains of the GAL4 protein in the subsequent Y2H 
analyses in step 5 (figure 3.1). Six recombination reactions were therefore set up (appendix 11). 
The enzymes that facilitate the recombination; Int, Xis and IHF (LR clonase II enzyme mix) were 
mixed with equal molar ratio of miniprep entry clone DNA and the destination vectors, and 
incubated at 25 °C overnight. The following morning proteinase K solution was added to 
terminate the enzyme activity. Aliquots from each reaction mixture were transformed into TOP 10 
One Shot chemically competent E. coli, and plated on gentamicin (pDEST
TM
32 vector) and 
ampicillin (pDEST
TM
22 vector) plates, and incubated at 37 °C overnight.  
 
Propagation of the destination vectors pDEST
TM
32 and pDEST
TM
22 was performed in XL 10-
Gold
®
 Ultracompetent E. coli cells, which strain is resistant to ccdB effects. The technique is 
described in appendix 9. 
 
3.4.1 Restriction enzyme analysis of expression constructs 
Restriction analysis was also performed on positive expression constructs following the 
recombination reaction, to confirm the presence of the genes in the destination vectors. In the 
recombination reaction, the chloramphenicol and ccdB gene are replaced by the genes of interest. 
The chloramphenicol and ccdB gene together constituted 1589 basepairs (bp), whilst 240 bp for 
CKS2, 894 bp for CDK1 AF and 897 bp for CDK2 AF were fused into the destination vectors 
instead. The vector generating the bait, pDEST
TM
32, constituted 12266 bp. pDEST
TM
22 (generate 
preys) had a size of 8930 bp.  
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Simple mathematical calculations where 1598 bp (the chloramphenicol and ccdB gene) was 
subtracted from the destination vector size and the inserted gene size was added, gave expression 
constructs of following sizes represented in the table 3.1. 
 
Table 3.1 Size of bait and prey plasmids. 
Expression construct Size (bp)* 
 
Bait 
pEXP
TM
32/CKS2 10917 
pEXP
TM
32/CDK1 AF 11571 
pEXP
TM
32/CDK2 AF 11574 
 
Prey 
pEXP
TM
22/CKS2 7581 
pEXP
TM
22/CDK1 AF 8235 
pEXP
TM
22/CDK2 AF 8238 
* For all correct recombinant clones the chloramphenicol and ccdB gene were cut out (1598 bp), whereas the desired 
gene was inserted. The gene sizes are described above. A simple mathematical calculation gave the expression 
constructs the following sizes represented in bold. 
 
Overnight cultures containing LB medium with appropriate antibiotics (appendix 5) were made in 
order to make glycerol stocks for storage (appendix 8). The plasmid DNA was purified from the 
E. coli cells using the alkaline lysis (miniprep) method described in appendix 6, and digested with 
SwaI enzyme for 2-4 hours as described in appendix 15. The enzyme digested fragments were 
analyzed under a UV transilluminator after GelRed staining, following gel electrophoresis. 
 
3.4.2 Sequencing 
To ascertain the presence and correct orientation of the insert into the destination vectors, the 
clones that appeared correct in the restriction enzyme analyses were subjected to nucleotide 
sequencing by GATC Biotech in Germany. Appropriate primers were designed and included in 
the shipment to GATC Biotech. These primers are described in appendix 1, table 2. The 
nucleotide sequences received in return from GATC Biotech, were compared with the correct 
nucleotide sequences of the CKS2, CDK1 and CDK2 genes (appendix 16), by using the internet 
based alignment tool; Basic Local Alignment Search Tool (BLAST) provided by NCBI (86). The 
results of the BLAST searches are shown in appendix 17. 
 
3.5 Transformation in S. cerevisiae MaV203 (step 4)  
In order to transform the bait and prey constructs into S. cerevisiae MaV203, it was necessary to 
first make a working plate with the yeast. This was done by transferring a small amount from the -
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80 °C glycerol stock in 0.8 % sodium chloride (appendix 18). Dilutions of this suspension were 
plated onto agar plates containing a blend of yeast extract, peptone, adenine and dextrose (YPAD), 
by the receipt described in appendix 21. Adenine was added because MaV203 has a mutation in 
the ade2 gene that accumulates a red pigment that slows growth (57). Addition of adenine delays 
this accumulation, resulting in enhanced growth rate. The genotype of S. cerevisiae MaV203 is 
described in appendix 22. The plates were incubated at 30 °C for 3-5 days depending on growth.  
 
In this thesis, interactions between CKS2 with both CDK1 and CDK2, and the interaction between 
two CKS2 molecules forming a dimer was investigated. The interactions were tested with the 
proteins fused to both domains of the GAL4 protein. The combinations of bait and prey constructs 
transformed into S. cerevisiae MaV203 are described in table 3.2. A modified lithium acetate 
method was used (appendix 19). 
 
Table 3.2  Transformation of experimental interactions. 
LEU2 Plasmid 
(BAIT) 
TRP1 Plasmid 
(PREY) 
Experimental 
interaction 
pEXP™32/CKS2 pEXP™22/CDK1 AF CKS2 and CDK1 AF 
pEXP™32/CDK1 AF pEXP™22/CKS2 
pEXP™32/CKS2 pEXP™22/CDK2 AF CKS2 and CDK2 AF 
pEXP™32/CDK2 AF pEXP™22/CKS2 
pEXP™32/CKS2 pEXP™22/CKS2 Dimerization of CKS2 
 
S. cerevisiae MaV203 contains the auxothropic mutations that are complemented by the bait and 
prey vectors (leu2 and trp1). The cells were therefore plated on solid SC (-leu-trp) medium 
(appendix 21) following transformation. The plates were incubated at 30 °C for 3-5 days 
depending on growth.   
 
 
Five control interactions were used in the Y2H analyses; these were therefore also transformed 
into S. cerevisiae MaV203 with the same technique. Three of the controls were based on the  
interaction of Krev1 with RalGDS (the Ral guanine nucleotide dissociator stimulator protein) 
(87;88). The interaction between the Krev1 and the wild-type of RalGDS (RalGDS-wt) is known 
to be a strong positive interaction in the Y2H system. As a weak positive interaction control, the 
interaction between Krev1 and the mutant1 of RalGDS (RalGDS-m1) were used. An interaction 
with Krev1 with a second mutant of RalGDS (RalGDS-m2) served as a negative control. In 
addition to these strong-weak-absent controls, to test that neither the bait nor the prey was able to 
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autoactivate the promoter on its own, each bait and prey were transformed into the S. cerevisiae 
with its corresponding empty bait and prey destination vector (negative activation controls). The 
five control interactions and their purpose are described in table 3.3. 
 
Table 3.3 Transformation of control interactions.  
LEU2 Plasmid 
(BAIT) 
TRP1 Plasmid 
(PREY) 
Purpose 
pEXP™32/Krev1 pEXP™22/RalGDS-wt Strong positive interaction control 
pEXP™32/Krev1 pEXP™22/RalGDS-m1 Weak positive interaction control 
pEXP™32/Krev1 pEXP™22/RalGDS-m2 Negative interaction control 
Bait plasmid pDEST™22 Negative activation control 
pDEST™32 Prey plasmid Negative activation control 
 
As an additional experiment, transformation of the genes present in high-copy number vectors 
(pGBK and pGAD) was also conducted. The same technique and S. cerevisiae strain were used. 
This experiment was performed to give an indication of whether non-detectable interactions could 
be detected when the proteins were expressed at high levels, compared to the low-level vectors 
(pDEST
TM
32 and pDEST
TM
22). pGBK function as a bait fusion vector, while the pGAD is the 
prey vector. The combinations of bait and prey constructs transformed into S. cerevisiae MaV203 
are described in table 3.4. 
 
Table 3.4 Transformation of the genes present in high copy-number vectors. 
LEU2 Plasmid 
(BAIT) 
TRP1 Plasmid 
(PREY) 
Experimental 
interaction 
pGBK/CKS2 pGAD/CDK1 AF CKS2 and CDK1 AF 
pGBK/CDK1 AF pGAD/CKS2 
pGBK/CKS2 pGAD/CDK2 AF CKS2 and CDK2 AF 
pGBK/CDK2 AF pGAD/CKS2 
 
3.6 S. cerevisiae two-hybrid analysis (step 5) 
As step five in figure 3.1 shows, the experimental interactions are scored by plating the bait and 
prey transformants onto selective plates. The transformation and Y2H analyses (step 4 and 5) were 
repeated once, and a total of fourteen transformants were conducted from each interaction (seven 
transformants in each analysis).  
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Overnight cultures with the transformed S. cerevisiae cells were made (appendix 20). The yeast 
cells were harvested the following day by centrifugation, and after two washing procedures with 
sodium chloride, optical density were measured at 600 nm (OD600). The suspensions were 
adjusted to OD ~ 1 with sodium chloride, and 10
-1
, 10
-2
, and 10
-3
 serial dilutions were prepared. 
10 μl aliquots of these four dilutions were spotted onto agar selection plates with a marked-up 
grid, as illustrated in figure 3.2. The OD ~ 1 concentration was spotted in the leftmost square of 
the lane, and the 10
-1
, 10
-2
, and 10
-3
 dilutions were applied in the remaining squares to the right. 
The OD adjustments ensured that approximately equal numbers of cells were plated on each plate, 
thereby facilitating comparison of growth between plates.  
 
 
 
 
 
 
 
 
Figure 3.2 Illustration of petri dish with a marked 
up grid. Four different dilutions of transformed 
S. cerevisiae suspensions are spotted from the left to 
the right. Six samples can fit into the plate.  
 
3.6.1 Control interactions 
Five out of the six lanes on the plate were controls. In lane 1, the strong positive interaction 
between the Krev1 and the wild-type of RalGDS (RalGDS-wt) was placed. The weak positive 
interaction control between Krev1 and the mutant1 of RalGDS (RalGDS-m1) was spotted in 
lane 2. A negative interaction control by the Krev1 interactions with a second mutant of RalGDS 
(RalGDS-m2) was applied in lane 3. The negative activation controls to test that neither the bait 
nor the prey was able to autoactivate the promoter, were applied in lane 4 and 5. In the very last 
lane (# 6), the experimental interaction was spotted. The five control-interactions and their 
purpose are described in table 3.3. 
 
3.6.2 Selection plates 
Four different synthetic complete (SC) selection plates were used in the Y2H analysis, and all four 
were lacking the amino acids leucine and tryptophan. Omitting these verified that both bait and 
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prey were present in the yeast cell, as the bait transcribe an enzyme in the leucine biosynthesis 
pathway, and the prey will synthesize an enzyme in the tryptophan pathway. If only one of the 
expression constructs were present, the cell should not be able to grow. The first plate SC (-leu-
trp) was the control plate, merely indicating that the cells contained both bait and prey plasmids. 
The SC (-leu-trp-his+10 mM 3-AT) scores for interactions using the HIS3 reporter gene, and 
should only grow if bait and prey interacts, thereby able themselves to produce histidine. 3-AT 
was added as a supplement to prevent false positives. The SC (-leu-trp-ura) plate scores for 
interactions using the URA3 reporter gene. As with the HIS3 plates; cells should only grow if bait 
and prey interacts, that means they were able themselves to produce uracil. The SC (-leu-
trp+0.2 % 5-FOA) was also a test for activation of the URA3 reporter, but will yield opposite 
phenotypes of the first URA3 test. Because 5-FOA was added, cells where the URA3 reporter is 
activated will not survive. In contrast, if no interaction occurs the cell will survive on the 5-FOA 
containing plate. The selection plates and their purpose are summarized in table 3.5. 
 
Table 3.5 The selections plates and their purposes. 
Selection plate Added supplement(s) Purpose 
Sc -leu-trp 
 
20 µg/ml uracil 
125 µg/ml L-histidine 
Transformation control 
Sc -leu-trp-his + 10 mM 3-AT 20 µg/ml uracil 
10 mM 3-AT 
HIS3 activation (positive selection) 
Sc -leu-trp-ura 
 
125 µg/ml L-histidine URA3 activation (positive selection) 
Sc -leu-trp + 5-FOA 
 
20 µg/ml uracil 
125 µg/ml L-histidine 
0.2 % 5-FOA 
URA3 activation (negative selection) 
 
3.6.3 Testing the interactions and interpretation of results 
Although only one single transformant could be tested on the plates since it included five controls, 
a second plate made from the same preparation as the first plate for the respective plates tested 
six more transformants. Not including controls on the second plate was justified because the SC 
agar with the appropriate supplements was mixed simultaneously in the same tube upon 
preparation (appendix 21). As a total volume of 25 ml constituted one petri dish, the agar and 
supplements were mixed in a tube to a final volume of 50 ml. The content was carefully shaken 
and split between two plates. Provided the container was indeed mixed well, ascertained that these 
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two plates were equal. No controls were therefore spotted on the second plate, as this plate was 
only used for six additional transformants of the experimental interactions.  
 
The plates were incubated at 30 °C for 3 days, whereafter the phenotypes of the cells were 
compared to the expected results provided by Invitrogen (66) in the figure 3.3: 
 
 
Figure 3.3 Expected results for the controls of theY2H analysis.  Control 1-3 is the strong, weak and absent 
control interaction provided by interactions between the Krev1 and different mutants of RalGDS. Control 4 and 5 are 
negative activation controls to test that neither the bait nor the prey was able to autoactivate the promoter. Figure 
modified from the manual from Invitrogen (66). 
 
3.6.4 High copy number vectors 
The same selection plates were used in the analyses for when the genes were present in the high-
copy number vectors (pGBK and pGAD), but only the three first controls were included, 
excluding the auto activation controls. The marked up grid drawn on the selection plates in this 
experiment fitted seven samples on each plate, and not six as in the Y2H analyses above. Only the 
interactions with CKS2 to the CDK1 AF and CDK2 AF (in both domains) were conducted and 
only one transformant of each were tested.  
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4 RESULTS 
4.1 PCR optimalization and cDNA amplification 
The gradient PCR was performed to experimentally determine the optimum primer annealing 
temperatures for the primers. Figure 4.1 show that amplification product was achieved in the range 
of 45 °C and 45.3 °C for CKS2, whereas for both CDK1 AF and CDK2 AF amplification product 
appeared at 45 °C. At temperatures higher than this, no amplification product was visible. The best 
annealing temperature was therefore 45 °C for all the primers. 
 
Figure 4.1 1.5 % agarose gel of cDNA of CKS2, CDK1 AF and CDK2 AF. Gradient PCR with temperatures in the 
range from 45 °C to 65 °C. M: 2 log DNA ladder. Lane 2-13: CKS2. Lane 14-25: CDK1 AF. Lane 26-37: CDK2 AF. 
 
For all three genes, the preparative PCR was set to a uniform temperature of 45 °C in the 
annealing phase. The PCR products analyzed by agarose gel electrophoresis (figure 4.2) showed a 
clear product band for all the three genes corresponding with the correct sizes (240 bp for CKS2, 
894 bp for CDK1 AF and 897 bp for CDK2 AF). The bands marked in red were excised from the 
gel and purified. The purified products were further used in the cloning reaction to make entry 
clones. 
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Figure 4.2  1.5 % agarose gel of PCR amplification products of CKS2, CDK1 AF and CDK2 AF.  Amplification 
performed under optimized temperature conditions. The positions and sizes (bp) of marker DNA fragments (lane M) 
are indicated at the left. The marked bands were excised out of the gel with a scalpel, and purified. 
 
4.2 Generation of entry clones 
Plasmid DNA from randomly selected transformants from the cloning reaction generating the 
entry clones were digested with the restriction enzymes NotI HF and AscI. Gel electrophoresis 
was performed to separate the cut fragments, and the results are shown in figures 4.3, 4.4 and 4.5 
for the three genes. An uncut and cut sample of each selected transformant was placed next to 
each other on the gel. The bands yielded by the two samples were used for comparison, where the 
uncut plasmid DNA serves as a control to determine whether the other plasmid had been cut or 
not. The lane that contained the digested sample was expected to yield two bands; one for the 
gene, and the other for the empty pENTR™/D-TOPO® vector. As described in section 2.8, 
different conformational forms of DNA migrate at different rates through the agarose gel (84). The 
samples of uncut circular entry clones were seen around 2000 bp. The cut empty pENTR™/D-
TOPO
®
 vector is linear and the band can be visualized close to 3000 bp.  
 
4.2.1 Entry clone containing the CKS2 gene 
Lane 1, 3, 5 and 7 in figure 4.3 contained uncut circular plasmid DNA of the CKS2 entry clone. 
Lane 2, 4, 6 and 8 are plasmid DNA of the double digested CKS2 entry clone, into 240 bp and 
2580 bp fragments. The two bands seen on the gel for the samples in lanes 4, 6 and 8 are 
consistent with these sizes, indicating that the CKS2 gene was present in the pENTR™/D-TOPO® 
vector. The bands for the CKS2 gene showed very weak bands. This was most likely due to the 
bigger size of the cut vector than the gene. Due to the weak CKS2 band, the sample in lane two 
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might also be correct even if the band for CKS2 was not visible. This was not investigated any 
further since the three other lanes had a visible CKS2 band. The clone in lane 6 was selected for 
the further experiments.  
         
 
Figure 4.3 1.5 % agarose gel of double digested CKS2 entry clone. 
The leftmost lane (M) shows the DNA marker 2-log ladder. The next lane (G) is gel-purified PCR product of the 
CKS2-gene. The following two and two lanes contains plasmid DNA from the same sample. The leftmost lane of the 
two is uncut plasmid DNA of a CKS2 entry clone, expected to yield one band. The rightmost lane of the two is the 
same plasmid DNA double digested with NotI HF and AscI, and is expected to yield two bands. The samples that 
appeared correct are marked with a red circle. 
     
4.2.2 Entry clone containing the CDK1 AF gene 
Figure 4.4 shows the results for digested entry clones containing the CDK1 AF gene. Lane 1, 3, 5 
and 7 are uncut circular plasmid DNA, while lane 2, 4, 6 and 8 contained plasmid DNA cut with 
the two restriction enzymes into 894 bp and 2580 bp fragments. The samples in lanes 4 and 8 
contained two bands which was consistent with the sizes of empty entry vector and the CDK1 AF 
gene. The clone in lane 4 was selected for the further experiments. 
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Figure 4.4 0.8 % agarose gel of double digested CDK1 AF entry clone. 
The leftmost lane (M) shows the DNA marker 2-log ladder, and the following lane (G) is gel-purified PCR product of 
the CDK1 AF-gene. Only the samples in lane 4 and 8 appear to be correct (marked in red).  
 
4.2.3 Entry clone containing the CDK2 AF gene 
Uncut circular plasmid DNA of the CDK2 AF entry clone was applied in lane 1, 3, 5, 7 and 9 
(figure 4.5). The cut fragments in lane 2, 4, 6, 8 and 10 contained plasmid DNA cut with the 
restriction enzymes into 897 bp and 2580 bp fragments. Only the sample in lane 2 contained two 
bands which were consistent with these sizes. This clone was therefore used in the further 
experiments. 
 
Figure 4.5  0.8 % agarose gel of digested CDK2 AF entry clone. The leftmost lane, marked M, shows the DNA 
marker (2-log ladder) and the following lane is gel-purified PCR product of the CDK2 AF-gene (marked G). Only the 
clone in lane 2 contained two bands which were consistent with the sizes of empty vector and the CDK2 AF-gene.  
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4.3 Generation of bait and prey expression constructs 
Following the recombination reaction between the entry clones and destination vectors, 
pDEST
TM
32 and pDEST
TM
22, the expression constructs were tested for the presence of gene 
inserts by digestion with SwaI. The resulting DNA fragments were separated according to size by 
electrophoresis, and the results are shown in the figures 4.6, 4.7 and 4.8.  Panel A in the figures 
shows the gene cloned as bait, while panel B is the gene cloned as prey. Empty destination vectors 
were also cut with SwaI to serve as a linear control, to compare the size of empty vectors to 
vectors with the inserted gene. These were placed in the second lane from the left in the gel 
(marked V), and showed a band consistent with their sizes of 12 266 bp for pDEST
TM
32 (panels 
A) and 8930 bp for pDEST
TM
22 (panels B) on all the gels. The samples marked with a red circle 
in the figures were selected for sequencing by GATC Biotech, Germany. 
4.3.1 CKS2 cloned as bait and prey  
Figure 4.6, panel A shows five transformants from the recombination reaction where CKS2 was 
cloned into pDEST
TM
32. A successful bait construct containing CKS2 should have a size of 
10 917 bp. The only transformant showing a band of this size was the one in lane 2. This clone 
was selected for sequencing. Eight transformants from the reaction where CKS2 was cloned into 
pDEST
TM
22 to generate prey constructs are shown in fig. 4.6.B. A correctly transformed construct 
should have a size of 7581 bp. All the eight transformants appeared to be consistent with this size. 
The clone in the first lane was selected for sequencing.  
 
Figure 4.6 Gelelectrophoresis of linearized bait and prey. 0.8 % agarose gel. The leftmost lane shows the DNA 
marker (2-log ladder), and the next lane is the linear control (pDEST
TM
32 in panel A, pDEST
TM
22 in panel B). Only 
the marked transformant in panel A appeared to be correct. In panel B, all eight transformants appeared to be correct, 
but only the one marked with the red circle was selected for sequencing.  
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4.3.2 CDK1 AF cloned as bait and prey  
Successful cloning of CDK1 AF as bait (panel A) and as prey (panel B) should yield bands of the 
sizes 11 571 bp and 8235 bp, respectively. Figure 4.7.A shows that all four transformants was 
above the 10 000 bp fragment of the DNA marker (2-log ladder), but slightly below the control 
size of 12 266 bp. All four transformants therefore seemed to be correct. The transformant in lane 
1 was selected for verification through sequencing. In panel B, the transformants in lane 1 and 2 
appeared to contain a fragment of the right size (8245 bp). The one in lane 2 was selected for 
sequencing.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Gelelectrophoresis of linearized bait and prey. The leftmost lane shows the DNA marker (2-log ladder), 
and the next lane was linear control of pDEST32 (marked V). The transformant in lane 1 in panel A and the 
transformant in lane 2 in panel B, was selected for sequencing,  
 
4.3.3 CDK2 AF cloned as bait and prey  
Correct recombinant products from the cloning of CDK2 AF as bait should yield a fragment of the 
size 11 574 bp on the agarose gel (panel A, figure 4.8). Since the four tested transformants 
appeared larger than 10 000 bp, but not as large as the empty vector control (12 266 bp), the 
analysis indicated that all the four transformants contained the gene. The transformant in lane 
1 was sequenced. Similar results can be seen for the cloning of CDK2 AF as prey (panel B, figure 
4.8); the band for the empty vector was consistent with its size of 8930 bp, while the eight 
transformants were somewhat below that size (should give a fragment of 8238 bp). Two 
transformants were sent to GATC Biotech for sequencing (lane 1 and 2).  
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Figure 4.8 Gelelectrophoresis of linearized bait and prey. The leftmost lane shows the DNA marker (2-log ladder), 
and the next lane was linear control of pDEST32. The transformant in lane 1 in panel A appeared correct and was 
selected for sequencing. In panel B, all the transformants appeared to be correct. The two transformants marked in the 
red circle were sequenced. 
 
4.3.4 Sequencing of the bait and prey constructs 
The nucleotide sequences of the transformants marked with a red circle in the figures 4.6, 4.7 and 
4.8 received in return by GATC Biotech, Germany, were compared with the correct nucleotide 
sequences of the CKS2, CDK1 and CDK2 genes (appendix 16). The results of these comparisons 
are described in appendix 17, and showed that successful cloning of the genes into the two 
expression vectors was achieved for all the three genes. The sequencing also verifies the presence 
of the CDK1 and CDK2 mutations on amino acid 14 and 15 (changed from threonine to alanine 
and tyrosine to phenylalanine, respectively). 
 
4.4 The two-hybrid analysis 
The Y2H analyses for the interactions between CKS2 to CDK1 AF and CDK2, and dimerization 
of two CKS2 molecules are shown in the figures 4.9 to 4.13. The transformation in S. cerevisiae 
and Y2H analysis was repeated once, and a total of fourteen transformants were conducted from 
each interaction (seven transformants in each analysis). Only one transformant is shown for each 
analysis.  
 
The four different selection plates used are described in table 3.5. All four plates were lacking 
leucine and tryptophan to select for the presence of both plasmids. The first plate (plate A) was 
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merely a positive transformation control to show that both bait and prey plasmids are present in 
the cell. The three next plates performed the test for reporter gene activation. In plate B, HIS3 
reporter activation was tested. 3-AT was added to reduce auto activation. In plate C and D, URA3 
reporter activation was tested, whereas plate C was the positive growth control, and plate D served 
as a negative growth control. Comparison of the experimental interactions with the controls were 
used to evaluate results (activation of HIS3 and URA3 reporter), and assess the strength of the 
interaction being tested (strong, weak or no interaction). The controls also verified that the plates 
were correct, according to the phenotypes these should produce described in figure 3.3. 
 
As the growth of the controls is common in all the Y2H analyses presented they will not be 
discussed any further under each section. Lane 1 was the strong positive interaction control and 
showed growth on plates A, B and C as expected, because the proteins Krev1 and RalGDS-wt are 
known to have a strong interaction in the Y2H system. No growth on plates D was also expected, 
as 5-FOA prevents cells containing strongly interacting proteins to grow. The weak positive 
interaction control in lane 2 between Krev1 and RalGDS-m1 showed growth only on plates A, B 
and D. This was consistent with that a weak interaction will activate the HIS3 reporter, but not the 
URA3 reporter in this system. The absent interaction control in lane 3 only showed growth on the 
control plates (A), and the 5-FOA containing plates (D), which were also consistent with the 
expected result for this control. Lane 4 and 5 were negative auto activation controls, and no 
growth should appear with these two controls except on the control plate and 5-FOA plate, 
indicating that neither of the plasmid constructs was able to activate the HIS3 and URA3 reporter. 
Lane 6 at the bottom was the test scoring for the experimental interaction. For all interactions, the 
second set of plates containing six more transformants shared the same result (data not shown) as 
the one interaction that is shown. The photographs for the selection plates are edited so that only 
the marked up grid is shown. 
 
Figure 4.14 shows the Y2H experiment where the cDNA of the genes are transformed into the 
high-copy number vectors (pGBK and pGAD). 
 
4.4.1 Interactions between CKS2 and CDK1 AF 
Lane six in figure 4.9 below shows the result obtained when CKS2 was fused as bait and 
CDK1 AF fused as prey. In figure 4.10 (lane six) the domains were swapped; CDK1 AF as bait 
whereas CKS2 as prey. Both two-hybrid analyses showed that CKS2 interacted with CDK1 AF by 
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activating the HIS3 reporter, regardless of whether CKS2 (figure 4.9) or CDK1 AF (figure 4.10) 
was cloned as the bait protein. The URA3 reporter on the other hand, was not activated in any of 
the two Y2H analyses performed. All fourteen transformants tested for this interaction gave these 
results. No signs of toxicity are observed as the growth on the control plates (plate A) were not 
reduced compared to the controls. 
 
CKS2 as bait, CDK1 AF as prey 
Lane LEU2 Plasmid 
(BAIT) 
TRP1 Plasmid 
(PREY) 
Purpose 
1 pEXP™32/Krev1 pEXP™22/RalGDS-wt Strong positive interaction control 
2 pEXP™32/Krev1 pEXP™22/RalGDS-m1 Weak positive interaction control 
3 pEXP™32/Krev1 pEXP™22/RalGDS-m2 Negative interaction control 
4 pEXP™32/CKS2 pDEST™22 vector (empty) Negative activation control 
5 pDEST™32 (empty) pEXP™22/CDK1 AF Negative activation control 
6 pEXP™32/CKS2 pEXP™22/CDK1 AF Test of interaction, sample #1 
 
 
                                 
Figure 4.9 S. cerevisiae Y2H analysis of CKS2 fused as bait and CDK1 AF fused as prey.  The figure shows yeast 
growth on selection plates. Plate A: Control plate. Plate B: Test for HIS3 reporter gene activation. Plate C and D: Test 
for URA3 reporter gene activation. The control interactions were spotted in lane 1-5, while the experimental 
interaction was applied in lane 6.  
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CDK1 AF as bait, CKS2 as prey 
Lane LEU2 Plasmid 
(BAIT) 
TRP1 Plasmid 
(PREY) 
Purpose 
1 pEXP™32/Krev1 pEXP™22/RalGDS-wt Strong positive interaction control 
2 pEXP™32/Krev1 pEXP™22/RalGDS-m1 Weak positive interaction control 
3 pEXP™32/Krev1 pEXP™22/RalGDS-m2 Negative interaction control 
4 pEXP™32/CDK1 AF pDEST™22 vector (empty) Negative activation control 
5 pDEST™32 (empty) pEXP™22/CKS2 Negative activation control 
6 pEXP™32/CDK1 AF pEXP™22/CKS2 Test of interaction, sample #1 
 
     
     
Figure 4.10 S. cerevisiae Y2H analysis of CDK1 AF fused as bait and CKS2 fused as prey. The figure shows 
yeast growth on selection plates. Plate A: Control plate. Plate B: Test for HIS3 reporter gene activation. Plate C 
and D: Test for URA3 reporter gene activation. The control interactions were spotted in lane 1-5, while the 
experimental interaction was applied in lane 6. 
 
4.4.2 Interactions between CKS2 and CDK2 AF 
The results obtained for the Y2H analyses of CKS2 interactions with CDK2 AF (figure 4.11 and 
4.12) displayed similar results as described for CKS2 and CDK1 AF. However, four out of the 
fourteen transformants tested in the analyses where CDK2 AF fused as bait and CKS2 fused as 
prey, did not activate the HIS3 reporter. The URA3 reporter was not activated in any of the 
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analyses. Additionally, no toxicity was shown in these analyses, indicated by the dense growth on 
the control plate. 
 
CKS2 as bait, CDK2 AF as prey 
Lane LEU2 Plasmid 
(BAIT) 
TRP1 Plasmid 
(PREY) 
Purpose 
1 pEXP™32/Krev1 pEXP™22/RalGDS-wt Strong positive interaction control 
2 pEXP™32/Krev1 pEXP™22/RalGDS-m1 Weak positive interaction control 
3 pEXP™32/Krev1 pEXP™22/RalGDS-m2 Negative interaction control 
4 pEXP™32/CKS2 pDEST™22 vector (empty) Negative activation control 
5 pDEST™32 (empty) pEXP™22/CDK2 AF  Negative activation control 
6 pEXP™32/CKS2 pEXP™22/CDK2 AF Test of interaction, sample #1 
 
  
 
Figure 4.11 S. cerevisiae Y2H analysis of CKS2 fused as bait and CDK1 AF fused as prey. The figure shows 
yeast growth on selection plates. Plate A: Control plate. Plate B: Test for HIS3 reporter gene activation. Plate C 
and D: Test for URA3 reporter gene activation. The control interactions were spotted in lane 1-5, while the 
experimental interaction was applied in lane 6. 
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CDK2 AF as bait, CKS2 as prey 
Lane LEU2 Plasmid 
(BAIT) 
TRP1 Plasmid 
(PREY) 
Purpose 
1 pEXP™32/Krev1 pEXP™22/RalGDS-wt Strong positive interaction control 
2 pEXP™32/Krev1 pEXP™22/RalGDS-m1 Weak positive interaction control 
3 pEXP™32/Krev1 pEXP™22/RalGDS-m2 Negative interaction control 
4 pEXP™32/CDK2 AF pDEST™22 vector (empty) Negative activation control 
5 pDEST™32 (empty) pEXP™22/CKS2 Negative activation control 
6 pEXP™32/CDK2 AF pEXP™22/CKS2 Test of interaction, sample #1 
 
 
 
 
Figure 4.12 S. cerevisiae Y2H analysis of CDK2 AF fused as bait and CKS2 fused as prey. The figure shows 
yeast growth on selection plates. Plate A: Control plate. Plate B: Test for HIS3 reporter gene activation. Plate C 
and D: Test for URA3 reporter gene activation. The control interactions were spotted in lane 1-5, while the 
experimental interaction was applied in lane 6. 
 
4.4.3 Dimerization of CKS2  
Lane six in figure 4.13 shows the result for the analysis scoring for an interaction between two 
CKS2 proteins. No interaction was detected with either the HIS3 reporter or the URA3 reporter. 
All fourteen transformants shared this result. 
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CKS2 as bait, CKS2 as prey 
Lane LEU2 Plasmid 
(BAIT) 
TRP1 Plasmid 
(PREY) 
Purpose 
1 pEXP™32/Krev1 pEXP™22/RalGDS-wt Strong positive interaction control 
2 pEXP™32/Krev1 pEXP™22/RalGDS-m1 Weak positive interaction control 
3 pEXP™32/Krev1 pEXP™22/RalGDS-m2 Negative interaction control 
4 pEXP™32/CKS2 pDEST™22 vector (empty) Negative activation control 
5 pDEST™32 (empty) pEXP™22/CKS2 Negative activation control 
6 pEXP™32/CKS2 pEXP™22/CKS2 Test of interaction, sample #1 
 
 
 
Figure 4.13 S. cerevisiae Y2H analysis of the interaction between two CKS2 proteins. The figure shows yeast 
growth on selection plates. Plate A: Control plate. Plate B: Test for HIS3 reporter gene activation. Plate C and D: Test 
for URA3 reporter gene activation. The control interactions were spotted in lane 1-5, while the experimental 
interaction was applied in lane 6. 
 
4.4.4 Test of CKS2-CDK interaction using high copy-number vectors  
On plate B in figure 4.14, a weak activation of the HIS3 reporter gene was shown for CKS2 
interactions to both CDK1 AF and CDK2 AF, tested in both domains. Growth was reduced 
compared to the controls in lane 1-3, and to the Y2H analyses above. This was best visualized in 
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the 10
-2
 and 10
-3
 dilution on the plates, and indicates a mild toxicity. No URA3 activation was 
detected. The results on plate D indicate severe toxicity during growth in 0.2 % 5-FOA. 
 
Lane LEU2 Plasmid 
(BAIT) 
TRP1 Plasmid 
(PREY) 
Purpose 
1 pEXP™32/Krev1 pEXP™22/RalGDS-wt Strong positive interaction control 
2 pEXP™32/Krev1 pEXP™22/RalGDS-m1 Weak positive interaction control 
3 pEXP™32/Krev1 pEXP™22/RalGDS-m2 Negative interaction control 
4 pGBK/CKS2 pGAD/CDK1 AF Test of interaction 
5 pGBK/CKS2 pGAD/CDK2 AF Test of interaction  
6 pGBK/CDK1 AF  pGAD/CKS2 Test of interaction  
7 pGBK/CDK2 AF pGAD/CKS2 Test of interaction  
 
 
 
Figure 4.14 S. cerevisiae Y2H analysis of the interaction of CKS2 to CDK1 AF and CDK2 AF present in high 
copy-number vectors. The figure shows yeast growth on selection plates. Plate A: Control plate. Plate B: Test for 
HIS3 reporter gene activation. Plate C and D: Test for URA3 reporter gene activation. The control interactions were 
spotted in lane 1-3, while the experimental interactions were applied in lane 4-7. 
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5 DISCUSSION 
 
5.1 CKS2 interactions with CDK1 and CDK2 were detected through the HIS3 
reporter gene 
The HIS3 reporter gene was activated in both CDK interactions, and it did not matter in which 
domain CKS2 was present. All fourteen transformants tested for each Y2H analysis shared this 
result, except when CDK2 AF was fused as bait and CKS2 was fused as prey. In this analysis four 
out of the fourteen transformants did not activate the reporter. A mild toxicity of CDK2 AF in 
yeast has however been described (89), and this might be the cause why an interaction was not 
observed for all transformants in this specific interaction.  
 
Although interactions were detected by the use of the HIS3 reporter gene, the possibility that some 
of these are spurious cannot be excluded, taken into consideration the leaky character the GAL1 
promoter possesses (18;57). On the other hand, because the results were so consistent it is 
reasonable to believe that this is in fact a true interaction. The interactions are also demonstrated in 
previous studies (2;3;17;44-46), which strengthen the possibility for the interactions to be true.  
 
5.2 CKS2 interactions with CDK1 and CDK2 were not detected through the 
URA3 reporter gene 
Establishment of the Y2H using the URA3 reporter gene was successful, considering the expected 
results of the controls where only the strongest protein interaction tested (the Krev1-RalGDS 
control) activated the reporter. The CKS2-CDK interactions were however not strong enough to 
be detected through this system. None of the transformants activated the reporter in either 
selection assays. Taken into account the strong repression of the URA3 reporter gene by the 
SPO13 promotor (16), failure of activating transcription should therefore not exclude them as true 
interactors. Combined with the results for HIS3 described above, the findings indicate that the 
CKS2 interactions with CDK1 and CDK2 are too weak to be detected by the URA3. 
 
An attempt was also made to activate the URA3 reporter by using high copy-number plasmids 
from a different system. Y2H analysis of S. cerevisiae MaV203 cells with CKS2, CDK1 AF and 
CDK2 AF present in the 2µ origin of replication vectors (pGAD and pGBK) were performed, but 
did not show activation of URA3. The result of the experiment indicates that MaV203 cells grow 
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poorly with this level of fusion protein expression, but the problem needs to be investigated 
further. It could also have to do with compatibilities between different yeast strains and plasmids.  
 
A prerequisite for the use of Y2H is that the interacting proteins are localized in the nucleus (58). 
Although it remains unknown where the binding of CKS2 to the CDKs takes place, studies have 
shown nuclear presence of both CKS2 and the CDKs (8;28;90). The reason for escaping detection 
should therefore not be derived from this Y2H limitation. 
  
The CDKs used in these experiments mimicked the dephosphorylated, active state as both CDK1 
and CDK2 contained two substitutions on amino acid 14 and 15 (20;21). Whether or not this is of 
any relevance to the binding of CKS2 is somewhat unclear, as CKS2 is shown to bind also to 
CDKs where only one of these mutations are present (3;17). In addition, Egan and Solomon (3) 
found that phosphorylation on T161 stimulated binding of CKS2. As Sunnvolls work did detect 
interactions although lacking this phosphorylation (17), the same CDKs were chosen for use in 
this project. It is however not certain if the strength to which CKS2 is able to bind is altered 
because of these modifications on the CDKs. Investigation of the binding with CDKs lacking 
these should be performed to see if a stronger interaction were provided.  
 
The robustness and low amount of false positives yielded by this reporter are however good 
arguments to continue the effort obtaining the interactions through this reporter. One approach 
could be modification of the SPO13 promotor by increasing the number of UASGAL binding sites. 
The URA3 system used here contains ten such binding sites (appendix 22).  Constructing different 
S. cerevisiae strains with different reporter genes may be another solution. The ADE2 gene also 
allows negative selection and can thus be used in a reverse screen (57). 
 
5.3 CKS2 dimerization could not be detected by the Y2H system 
The interaction between two CKS2 proteins forming a dimer was also assessed with the same 
Y2H technique, but this interaction was not detected with either the HIS3 or URA3 reporter gene. 
As the CKS2 dimer could be an inactive form in respect to CDK binding, inhibition of the dimers 
does not have any therapeutic potential at present. The objective behind the investigation of this 
interaction was rather to provide more insight into the function of CKS2. 
  The dimerization of two CKS2 molecules is reported to be an unusual type of binding, so far 
only seen in two other proteins; the diphtheria toxin and seminal RNase (50). Other unknown 
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contributing factors needed for dimerization that is not present in the Y2H system, may be the 
reason why it was left undetected. 
 
5.4 Further prospects 
The work carried out as part of this thesis, demonstrates that development of a screen for 
inhibition of CKS2 interaction can be challenging. It also highlights the value of utilizing multiple 
reporters. In an effort to counteract the obstacles of URA3 activation, it could be interesting to 
perform experiments using non-mutated CDKs to investigate if this provides a stronger 
interaction. Using a system with increased numbers of GAL4 binding sites or other reporter genes 
could also be useful. 
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Appendix 1 
 
Primers for polymerase chain reaction (PCR) and sequencing 
 
 
Table.1. Primers for use in PCR amplification of CKS2, CDK1 AF and CDK2 AF: 
 
Gene Direction Sequence 
 
CKS2 
Forward  5’ – CAC CAT GGC CCA CAA GCA G -3’   
Reverse  5’ – TCA TTT TTG TTG ATC TTT TGG AAG AGG -3’ 
 
CDK1 AF 
Forward  5’- CAC CAT GGA AGA TTA TAC CAA AAT AG -3’ 
Reverse  5’- CTA CAT CTT CTT AAT CTG ATT GTC C -3’ 
 
CDK2 AF 
Forward  5’- CAC CAT GGA GAA CTT CCA AAA GG -3’ 
Reverse  5’- TCA GAG TCG AAG ATG GGG TAC -3’ 
 
 
 
 
 
 
Table.2. Primers for use in sequencing of pEXP
TM
32-gene and pEXP
TM
22-gene (GATC Biotech, 
Germany):  
 
 Direction Sequence 
 
pDEST
TM
32 
Forward  5’ – CAC-AGA-TAG-ATT-GGC-TTC-AGT-GGA-G – 3’   
Reverse  5’ – AGC-CGA-CAA-CCT-TGA-TTG-GAG –3’ 
 
pDEST
TM
22 
Forward  5’– GCG-TAT-AAC-GCG-TTT-GGA-ATC –3’ 
Reverse  5’– CCG-ACA-ACC-TTG-ATT-GGA-GAC –3’ 
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Appendix 2 
 
Protocol for PCR of CKS2, CDK1 AF and CDK2 AF genes 
 
 
a. Gradient PCR reaction: 
 
The protocol Pfu Ultra ΙΙ Fusion HS DNA Polymerase from Stratagene is used. 
 
1) Add the following components in the described order. Mix gently before adding the DNA 
polymerase. 
 
 pGBK/CKS2 pGBK/CDK1 AF pGBK/CDK2 AF 
Distilled water - - - 
10x PfuUltra ΙΙ reaction buffer 10 10 10 
dNTP mix (25 mM each dNTP) 2,5 2,5 2,5 
Vector DNA (10 ng) - - - 
Primer FW (10 µM) 2 2 2 
Primer RW (10 µM) 2 2 2 
Pfu Ultra ΙΙ fusion HS DNA 
polymerase 
2 2 2 
Total reaction volume (µl) 100 100 100 
 
2) Aliquot the reaction mixes into twelve PCR tubes for each reaction  
(8 µl in each tube). 
 
3) Carry out PCR using the following amplification cycles: 
 
 
 
 
 
 
 
 
 
4) Store amplified DNA at 4 °C, or analyze directly on agarose gel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial step: 2 min  95 °C  (initial denaturation) 
30 cycles: 20 sec  95 °C  (denaturation) 
  20 sec  55 °C ± 10 °C (primer annealing) 
  20 sec  72 °C  (elongation) 
Final step: 10 min  55 °C  (final elongation) 
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b. Preparative PCR reaction: 
 
1) The second PCR was performed with the same amount of components as described in 
appendix 2a, but with the following amplification cycle: 
 
 
 
 
 
 
 
 
 
 
 
2) Store amplified DNA at 4 °C or analyze it directly on agarose gel, followed by gel 
purification (appendix 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial step: 2 min  95 °C  (initial denaturation) 
30 cycles: 20 sec  95 °C  (denaturation) 
  20 sec  45 °C  (primer annealing) 
  20 sec  72 °C  (elongation) 
Final step: 10 min  55 °C  (final elongation) 
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Appendix 3 
 
Protocol for analysis by gel electrophoresis 
 
 
1) Add appropriate amount* of agarose powder and 1 x TAE buffer to a 250 ml bottle.  
2) Heat the mixture in the microwave oven and boil and swirl the solution until the agarose 
powder is completely dissolved. 
3) Let the mixture cool down and pour it into a gel rack. 
4) Apply an appropriate comb for forming the sample wells in the gel**. 
5) Allow the gel to set completely at room temperature (25-30 minutes). 
6) Remove the comb and transfer the gel to an electrophoresis tank containing 
enough 1 x TAE buffer to cover the gel.  
7) Prepare the DNA ladder and samples for loading using loading buffer (for receipt, see 
appendix 21). Loading volume is dependent upon the type of comb used (well thickness and 
length) and thickness of the gel. 
8) Load the DNA samples along with a suitable DNA marker to individual wells. 
9) Run the gel at 100-150 V until the DNA fragments are clearly separated.  
10) Immerse the gel in stain*** and allow to stain for 15-30 minutes. 
11) Examine the gel by UV light and photograph the gel (when appropriate, excise the desired 
gel fragments with a scalpel). 
 
 
* Determine the amount of agarose powder required to make the desired agarose gel concentration 
and volume. Example: For a 1% agarose gel, add 1 gram of agarose to 100 ml of 1x TAE buffer. 
 
** For purification of PCR product: Tape up 3-4 teeth of the comb to form one large narrow well.  
 
*** 100 ml dH2O and 30 μl 10 000xGelRed 
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Appendix 4 
 
Protocol for gel purification of PCR products 
 
Wizard ® SV Gel and PCR Clean-Up System from Promega is used for this purpose. Modified 
from Quick Protocol, following the steps for DNA purification by centrifugation. 
 
Dissolving the Gel Slice 
 
1) Following electrophoresis, excise bands from gel while visualizing the bands on a UV 
transilluminator. Collect the gel fragments into 1.5 ml microcentrifuge tubes. 
2) Add 10 μl of membrane binding solution per 10 mg of excised gel. Vortex and incubate at 
50-65 °C until the gel slice is completely dissolved. 
 
Binding of DNA 
 
3) Insert SV minicolumn into collection tube. 
4) Transfer dissolved gel mixture to the minicolumn assembly. Incubate at room temperature 
for 1 minute. 
5) Centrifuge at 14 000 rpm for 1 minute. Discard flowthrough and reinsert minicolumn into 
collection tube. 
 
Washing 
 
6) Add 700 μl of membrane wash solution. Centrifuge at 14 000 rpm for 1 minute. Discard 
flowthrough and reinsert minicolumn into collection tube. 
7) Repeat step 6 with 500 μl of membrane wash solution. Centrifuge at 14 000 rpm for 
5 minutes. 
8) Empty the collection tube and recentrifuge the column assembly for 1 minute with the 
microcentrifuge lid open to allow evaporation of any residual ethanol. 
 
Elution 
 
9) Transfer minicolumn to a clean 1.5 ml microcentrifuge tube. 
10) Add 30 μl of nuclease-free water to the minicolumn. Incubate at room temperature for 
1 minute. Centrifuge at 14 000 rpm for 1 minute. 
11) Discard minicolumn, and measure DNA concentration.  
12) Store DNA at -20 °C.  
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Appendix 5 
 
Protocol for preparation of bacterial culture 
 
 
Preparation of E. coli overnight culture: 
- Transfer a small amount of the appropriate -80 °C glycerol stock of bacterial culture to a 
flask containing 100 ml LB medium and appropriate antibiotics*.  
- Incubate at 37 °C overnight in a shaking water bath. 
 
 
*  Plasmid   Antibiotic resistance gene  Concentration, µg/ml 
     pGBKT7   Kanamycin   50 
     pGADT7   Ampicillin   100 
     pENTR™/D-TOPO®  Kanamycin    50  
     pDEST
TM
32   Gentamicin   2  
     pDEST
TM
22   Ampicillin   100  
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Appendix 6 
 
Protocol for plasmid purification, miniprep 
 
Wizard® Plus SV Minipreps DNA Purification System from Promega is used for this purpose. 
Modified from Quick Protocol, following the steps for centrifugation protocol. 
 
Production of Cleared Lysate 
1) Pellet 1-10 ml overnight culture of E. coli cells containing plasmid at 15 000 
rpm for 5 minutes, and remove the supernatant. 
2) Thoroughly resuspend pellet with 250 μl cell resuspension solution. 
3) Add 250 μl cell lysis solution to each sample; invert 4 times to mix. Incubate until the cell 
suspension clears (1-5 minutes). 
4) Add 10 μl alkaline protease solution; invert 4 times to mix. Incubate 5 minutes at room 
temperature. 
5) Add 350 μl neutralization solution; invert 4 times to mix. 
6) Centrifuge at 15 000 rpm for 10 minutes at room temperature. 
 
Binding of Plasmid DNA 
7) Insert spin column into collection tube. 
8) Decant cleared lysate into spin column. 
9) Centrifuge at 15 000 rpm for 1 minute at room temperature. Discard 
flowthrough and reinsert column into collection tube. 
 
Washing 
10) Add 750 μl wash solution (with ethanol added). Centrifuge at 15 000 rpm for 
1 minute. Discard flowthrough and reinsert column into collection tube. 
11) Repeat step 10 with 250 μl wash solution. 
12) Centrifuge at 15 000 rpm for 2 minutes at room temperature. 
 
Elution 
13) Transfer spin column to a sterile 1.5 ml microcentrifuge tube, being careful 
not to transfer any of the column wash solution with the spin column. 
14) Add 50 μl of nuclease-free water to the spin column. Centrifuge at 15 000 rpm 
for 1 minute. 
15) Discard column, measure the concentration of DNA and store at -20 °C. 
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Appendix 7 
 
Protocol for plasmid purification, midiprep 
 
 
Modified from JETSTAR 2.0 Plasmid Mini/Midi/ Maxi-Protocol, following the steps stated for 
Midi which is suitable for low copy plasmids (0.2-1 μg DNA/ml LB medium).  
 
Day 1. Preparation of E. coli overnight culture: 
- Transfer a small amount of the appropriate -80 °C glycerol stock of bacterial culture to a 
flask containing 100 ml LB medium and appropriate antibiotics.  
- Incubate at 37 °C overnight in a shaking water bath. 
 
Day 2. 
1) Column equilibration: add 10 ml of solution E4 to the column. Allow it to empty by gravity 
flow, do not force out remaining solution. 
2) Harvesting bacterial cells: pellet the overnight culture (centrifuge at 4 °C, 8500 rpm for 7 
minutes). Remove all traces of LB medium. 
3) Cell resuspension: resuspend the pellet with 4 ml of solution E1. 
4) Cell lysis: add 4 ml of solution E2. Mix gently by inverting the tube until the lysate appears 
to be homogenous. Incubate at room temperature for 5 minutes. 
5) Neutralization: add 4 ml of solution E3 and mix immediately by multiple inverting. 
Centrifuge at room temperature, 8500 rpm for 10 minutes. 
6) Column loading: transfer the supernatant from step 5 to the equilibrated column, and allow 
the lysate to run by gravity flow. 
7) Column washing: add 10 ml of solution E5, and allow emptying by gravity flow. Repeat 
step 7.  
8) Plasmid elution: switch tube under the column. Add 5 ml of solution E6 to the column and 
allow to run by gravity flow.  
9) Plasmid precipitation: precipitate the DNA with 3.5 ml isopropanol and centrifuge at 4 °C, 
8500 rpm for 30 minutes. Discharge the supernatant.  
10) Wash the plasmid DNA with 1 ml 70 % ethanol. Centrifuge at 4 °C, 8500 rpm for 5-10 
minutes. Remove the ethanol by using a pipette. 
11) Air dry the DNA pellet for at least 10 minutes. 
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12) Redissolve the DNA pellet in 100 μl nuclease-free water. Measure the concentration of 
DNA and store at -20 °C. 
 
Solutions supplied with kit: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Solution E1 (Cell Resuspending)   Store at RT 
50 mM  Tris 
10 mM  EDTA 
HCl ad pH 8.0 
 
The RNase-containing solution E1 must be stored at 4°C. 
 
Solution E2 (Cell Lysis)    Store at RT 
200 mM  NaOH 
1.0 %   SDS (w/v) 
 
Solution E3 (Neutralization)    Store at RT 
3.1 M   potassium acetate 
acetic acid ad pH 5.5 
 
Solution E4 (Column Equilibration)   Store at RT 
600 mM  NaCl 
100 mM  sodium acetate 
0.15 %  TritonX-100 
acetic acid ad pH 5.0 
 
Solution E5 (Column Washing)    Store at RT 
800 mM  NaCl 
100 mM  sodium acetate 
acetic acid ad pH 5.0 
 
Solution E6 (DNA Elution)    Store at RT 
1250 mM  NaCl 
100 mM  Tris 
HCl ad pH 8.5 
      
     RT = room temperature 
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Appendix 8 
 
Protocol for glycerol stock preparation 
 
Prepare glycerol stocks of E. coli and S. cerevisiae as follows: 
 
1) Combine equal amounts of overnight culture and 50 % glycerol to a 2 ml cryovial. 
2) Vortex the vial vigorously to ensure even mixing of the culture and the glycerol. 
3) Store at -80 °C. 
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Appendix 9 
 
Protocol for transformation of XL 10-Gold
®
 Ultracompetent E. coli 
 
Modified protocol provided by Stratagene. 
 
1) Pre-chill a 2 ml tube on ice. 
2) Thaw the XL 10 Gold® cells on ice. When thawed, gently mix the cells by pipetting, and 
transfer 100 μl to the pre-chilled tube. 
3) Add 4 μl β-Mercaptoethanol and incubate on ice for 10 minutes, vortexing gently every 
2 minutes. 
4) Add 0.1 – 50 ng of the experimental DNA, swirl gently and incubate on ice for 30 minutes. 
5) Heat-shock the tube at 42 °C for 30 seconds. 
6) Incubate the tube on ice for 2 minutes. 
7) Add 900 μl preheated (42 °C) LB, and incubate at 37 °C for 1 hour with shaking at 300 rpm. 
8) Prepare serial dilutions (10-1 - 10-5) with LB medium for each sample. 
9) Plate 100 μl of each dilution on LB plates containing appropriate antibiotics. 
10) Incubate the plates at 37 °C overnight. 
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Appendix 10  
 
Protocol for construction of entry clone: TOPO cloning reaction 
 
Modified protocol provided from Invitrogen™: pENTR™ Directional TOPO® Cloning Kit. 
 
The following equation is used to calculate the amount of PCR product (insert) in the reaction; 
 
 
 
Where; pENTR™/D-TOPO® = 2580 bp, CKS2 = 240 bp, CDK1 AF: 894 bp,  
CDK2 AF = 897 bp.  
The recommended insert:vector molar ratio is 0,5:1 – 2:1. The ratio1:1 provided correct result for 
CKS2 and CDK1 AF, while the correct clone for CDK2 AF was achieved with ratio 0.5:1.  
 
 
1) Add the following components in the described order, mix gently and incubate for 5 minutes 
at room temperature. 
 
PCR product (insert)  0.5 – 4 µl  
Salt solution   1 µl     
Sterile water    add to a final volume of 5 µl 
pENTR™/D-TOPO® vector 1 µl 
Final volume:   6 µl 
 
2) Place the reaction on ice. 
3) Add 2 µl from step 2 into a vial of One Shot® TOP10 Chemically Competent E .coli and 
mix gently.  
4) Incubate on ice for 30 minutes. 
5) Heat-shock the cells for 30 seconds at 42 °C without shaking. 
6) Immediately transfer the tubes to ice and add 250 µl of room temperature LB medium. 
7) Shake the tube (200 rpm) at 37 °C for 1 hour. 
8) Spread 100 µl directly per sample onto a selective plate. 
9) Centrifuge the remaining suspension at 15000 rpm for 5 minutes, and discharge the 
supernatant. Resuspend the cell pellet in 100 µl LB medium, and spread it onto a second 
plate. 
10) Incubate the plates at 37 °C overnight. 
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Appendix 11 
 
Protocol for construction of bait and prey plasmids: LR clonase reaction 
 
Modified protocol provided from Invitrogen™: Gateway® LR Clonase II Enzyme Mix. 
 
 
1) Add the following components to a 1.5 ml microcentrifuge tube at room temperature and 
mix: 
 
Entry clone (150 ng)    1-7 µl 
Destination vector (150 ng/µl)   1 µl 
TE buffer, pH 8.0    to 8 µl 
 
2) Thaw on ice the LR Clonase II enzyme mix for about 2 minutes. Vortex the LR Clonase II 
enzyme mix briefly twice (2 seconds each time).  
3) To each sample (Step 1, above), add 2 µl of LR Clonase II enzyme mix to the reaction and 
mix well by vortexing briefly twice. Microcentrifuge briefly.  
4) Incubate reactions at 25 °C overnight.  
5) Add 1 µl of the proteinase K solution to each sample and vortex briefly. Incubate samples at 
37 °C for 10 minutes. 
Transformation 
6) Add 1 µl from each LR-reaction mixture into a vial of TOP 10 One Shot chemically 
competent E. coli and mix gently. 
7) Incubate on ice for 30 minutes. 
8) Heat-shock the cells for 30 seconds at 42 °C. 
9) Add 250 µl of room temperature LB medium. 
10) Shake the reaction mix at 300 rpm for 1 hour at 37 °C. 
11) Plate the transformation mix on LB plates supplemented with appropriate antibiotics. 
12) Incubate overnight at 37 °C. 
 
 
 
 
 
  - 75 - 
Appendix 12 
 
Maps and features of plasmids: pENTR™/D-TOPO®, 
pDEST™32 and pDEST™22 
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Appendix 13 
 
Restriction map for pENTR™/D-TOPO®-gene, 
pDEST™32-gene and pDEST™22-gene 
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Appendix 14 
 
Protocol for restriction analysis of transformants from TOPO cloning reaction 
 
1) Set up the restriction enzyme digest as shown below (listed in order of addition): 
 
Nuclease-free water  - 
10xNEBuffer4   5 
10xBSA    5   
0.5 – 1 µg DNA   - 
NotI HF enzyme  0.5 
AscI enzyme   1 
Total volume   50 µl 
 
2) Gently flick the tubes to mix the reaction. 
3) Incubate reaction tubes for 2-4 hours at 37 °C. 
4) Store at -20 °C after inactivation of the enzymes at 65 °C for 20 minutes, or add loading dye 
and load samples directly onto agarose gel for electrophoresis. 
5) Stain the gel with GelRed and photograph the gel under UV light. 
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Appendix 15 
 
Protocol for restriction analysis of transformants from LR Clonase reaction 
 
 
1) Set up the restriction enzyme digest as shown below (listed in order of addition): 
 
Nuclease-free water - 
10xNEBuffer3   5 
10xBSA   5   
0.5 – 1 µg DNA  - 
SwaI enzyme  3 
Total volume  50 µl 
 
2) Gently flick the tubes to mix the reaction. 
3) Incubate reaction tubes for 2-4 hours at 25 °C. 
4) Store at -20 °C after inactivation of the enzymes at 65 °C for 20 minutes, or add loading dye 
and load samples directly onto agarose gel for electrophoresis. 
5) Stain the gel with GelRed and photograph the gel under UV light. 
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Appendix 16 
 
Nucleotide sequences of the CKS2, CDK1 and CDK2 genes 
 
These nucleotide sequences are obtained from internet resources of the National Center for 
Biotechnology Information, NCBI. 
 
 
 
CKS2 240 bp 
 
ATGGCCCACAAGCAGATCTACTACTCGGACAAGTACTTCGACGAACACTACGAGTACCGGCATGTTATGT 
TACCCAGAGAACTTTCCAAACAAGTACCTAAAACTCATCTGATGTCTGAAGAGGAGTGGAGGAGACTTGG 
TGTCCAACAGAGTCTAGGCTGGGTTCATTACATGATTCATGAGCCAGAACCACATATTCTTCTCTTTAGA 
CGACCTCTTCCAAAAGATCAACAAAAATGA 
 
 
 
 
CDK1 (variant 1) 894 bp 
 
 
ATGGAAGATTATACCAAAATAGAGAAAATTGGAGAAGGTACCTATGGAGTTGTGTATAAGGGTAGACA 
CAAAACTACAGGTCAAGTGGTAGCCATGAAAAAAATCAGACTAGAAAGTGAAGAGGAAGGGGTTCCTAGT 
ACTGCAATTCGGGAAATTTCTCTATTAAAGGAACTTCGTCATCCAAATATAGTCAGTCTTCAGGATGTGC 
TTATGCAGGATTCCAGGTTATATCTCATCTTTGAGTTTCTTTCCATGGATCTGAAGAAATACTTGGATTC 
TATCCCTCCTGGTCAGTACATGGATTCTTCACTTGTTAAGAGTTATTTATACCAAATCCTACAGGGGATT 
GTGTTTTGTCACTCTAGAAGAGTTCTTCACAGAGACTTAAAACCTCAAAATCTCTTGATTGATGACAAAG 
GAACAATTAAACTGGCTGATTTTGGCCTTGCCAGAGCTTTTGGAATACCTATCAGAGTATATACACATGA 
GGTAGTAACACTCTGGTACAGATCTCCAGAAGTATTGCTGGGGTCAGCTCGTTACTCAACTCCAGTTGAC 
ATTTGGAGTATAGGCACCATATTTGCTGAACTAGCAACTAAGAAACCACTTTTCCATGGGGATTCAGAAA 
TTGATCAACTCTTCAGGATTTTCAGAGCTTTGGGCACTCCCAATAATGAAGTGTGGCCAGAAGTGGAATC 
TTTACAGGACTATAAGAATACATTTCCCAAATGGAAACCAGGAAGCCTAGCATCCCATGTCAAAAACTTG 
GATGAAAATGGCTTGGATTTGCTCTCGAAAATGTTAATCTATGATCCAGCCAAACGAATTTCTGGCAAAA 
TGGCACTGAATCATCCATATTTTAATGATTTGGACAATCAGATTAAGAAGATGTAG 
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CDK2 (variant 1) 897 bp 
 
ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCACGTACGGAGTTGTGTACAAAGCCAGAAACA 
AGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAGACTGAGGGTGTGCCCAGTAC 
TGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCATCCTAATATTGTCAAGCTGCTGGATGTCATT 
CACACAGAAAATAAACTCTACCTGGTTTTTGAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCT 
CTGCTCTCACTGGCATTCCTCTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTT 
CTGCCATTCTCATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC 
ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACCCATGAGGTGG 
TGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTATTCCACAGCTGTGGACATCTG 
GAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGGGCCCTATTCCCTGGAGATTCTGAGATTGAC 
CAGCTCTTCCGGATCTTTCGGACTCTGGGGACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGC 
CTGATTACAAGCCAAGTTTCCCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGATGA 
AGATGGACGGAGCTTGTTATCGCAAATGCTGCACTACGACCCTAACAAGCGGATTTCGGCCAAGGCAGCC 
CTGGCTCACCCTTTCTTCCAGGATGTGACCAAGCCAGTACCCCATCTTCGACTCTGA 
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Appendix 17 
 
Sequencing 
 
A comparison of the nucleotide sequences received in return from GATC Biotech (Germany) with 
the correct gene sequences were performed using the Basic Local Alignment Search Tool 
(BLAST) provided by NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi).  
 
Appropriate primers were prepared (appendix 1) and shipped along with the samples. FW is 
forward primer, RW is reverse primer. 
 
Query: correct gene sequence 
Subject: nucleotide sequence received from GATC Biotech, Germany 
 
 
Result of BLAST search for CKS2 cloned into pEXP32, FW: 
>lcl|55809  
Length=920 
 
 Score =  444 bits (240),  Expect = 4e-129 
 Identities = 240/240 (100%), Gaps = 0/240 (0%) 
 Strand=Plus/Plus 
 
Query  1    ATGGCCCACAAGCAGATCTACTACTCGGACAAGTACTTCGACGAACACTACGAGTACCGG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  131  ATGGCCCACAAGCAGATCTACTACTCGGACAAGTACTTCGACGAACACTACGAGTACCGG  190 
 
Query  61   CATGTTATGTTACCCAGAGAACTTTCCAAACAAGTACCTAAAACTCATCTGATGTCTGAA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  191  CATGTTATGTTACCCAGAGAACTTTCCAAACAAGTACCTAAAACTCATCTGATGTCTGAA  250 
 
Query  121  GAGGAGTGGAGGAGACTTGGTGTCCAACAGAGTCTAGGCTGGGTTCATTACATGATTCAT  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  251  GAGGAGTGGAGGAGACTTGGTGTCCAACAGAGTCTAGGCTGGGTTCATTACATGATTCAT  310 
 
Query  181  GAGCCAGAACCACATATTCTTCTCTTTAGACGACCTCTTCCAAAAGATCAACAAAAATGA  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  311  GAGCCAGAACCACATATTCTTCTCTTTAGACGACCTCTTCCAAAAGATCAACAAAAATGA  370 
 
 
Results of BLAST search for CDK1 AF cloned into pEXP32, FW: 
>lcl|16385  
Length=1017 
 
 Score = 1596 bits (864),  Expect = 0.0 
 Identities = 877/885 (99%), Gaps = 1/885 (0%) 
 Strand=Plus/Plus 
 
Query  1     ATGGAAGATTATACCAAAATAGAGAAAATTGGAGAAGGTACCTATGGAGTTGTGTATAAG  60 
             ||||||||||||||||||||||||||||||||||||||| ||| |||||||||||||||| 
Sbjct  131   ATGGAAGATTATACCAAAATAGAGAAAATTGGAGAAGGTGCCTTTGGAGTTGTGTATAAG  190 
 
Query  61    GGTAGACACAAAACTACAGGTCAAGTGGTAGCCATGaaaaaaaTCAGACTAGAAAGTGAA  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  191   GGTAGACACAAAACTACAGGTCAAGTGGTAGCCATGAAAAAAATCAGACTAGAAAGTGAA  250 
 
Query  121   GAGGAAGGGGTTCCTAGTACTGCAATTCGGGAAATTTCTCTATTAAAGGAACTTCGTCAT  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  251   GAGGAAGGGGTTCCTAGTACTGCAATTCGGGAAATTTCTCTATTAAAGGAACTTCGTCAT  310 
 
Query  181   CCAAATATAGTCAGTCTTCAGGATGTGCTTATGCAGGATTCCAGGTTATATCTCATCTTT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  311   CCAAATATAGTCAGTCTTCAGGATGTGCTTATGCAGGATTCCAGGTTATATCTCATCTTT  370 
 
Query  241   GAGTTTCTTTCCATGGATCTGAAGAAATACTTGGATTCTATCCCTCCTGGTCAGTACATG  300 
  - 85 - 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  371   GAGTTTCTTTCCATGGATCTGAAGAAATACTTGGATTCTATCCCTCCTGGTCAGTACATG  430 
 
Query  301   GATTCTTCACTTGTTAAGAGTTATTTATACCAAATCCTACAGGGGATTGTGTTTTGTCAC  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  431   GATTCTTCACTTGTTAAGAGTTATTTATACCAAATCCTACAGGGGATTGTGTTTTGTCAC  490 
 
Query  361   TCTAGAAGAGTTCTTCACAGAGACTTAAAACCTCAAAATCTCTTGATTGATGACAAAGGA  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  491   TCTAGAAGAGTTCTTCACAGAGACTTAAAACCTCAAAATCTCTTGATTGATGACAAAGGA  550 
 
Query  421   ACAATTAAACTGGCTGATTTTGGCCTTGCCAGAGCTTTTGGAATACCTATCAGAGTATAT  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  551   ACAATTAAACTGGCTGATTTTGGCCTTGCCAGAGCTTTTGGAATACCTATCAGAGTATAT  610 
 
Query  481   ACACATGAGGTAGTAACACTCTGGTACAGATCTCCAGAAGTATTGCTGGGGTCAGCTCGT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  611   ACACATGAGGTAGTAACACTCTGGTACAGATCTCCAGAAGTATTGCTGGGGTCAGCTCGT  670 
 
Query  541   TACTCAACTCCAGTTGACATTTGGAGTATAGGCACCATATTTGCTGAACTAGCAACTAAG  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  671   TACTCAACTCCAGTTGACATTTGGAGTATAGGCACCATATTTGCTGAACTAGCAACTAAG  730 
 
Query  601   AAACCACTTTTCCATGGGGATTCAGAAATTGATCAACTCTTCAGGATTTTCAGAGCTTTG  660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  731   AAACCACTTTTCCATGGGGATTCAGAAATTGATCAACTCTTCAGGATTTTCAGAGCTTTG  790 
 
Query  661   GGCACTCCCAATAATGAAGTGTGGCCAGAAGTGGAATCTTTACAGGACTATAAGAATACA  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  791   GGCACTCCCAATAATGAAGTGTGGCCAGAAGTGGAATCTTTACAGGACTATAAGAATACT  850 
 
Query  721   TTTCCCAAATGGAAACCAGGAAGCCTAGCATCCCATGTCAAAAACTTGGATGAAAATGGC  780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  851   TTTCCCAAATGGAAACCAGGAAGCCTAGCATCCCATGTCAAAAACTTGGATGAAAATGGN  910 
 
Query  781   -TTGGATTTGCTCTCGAAAATGTTAATCTATGATCCAGCCAAACGAATTTCTGGCAAAAT  839 
              |||||||||||  |||||||||||||||||||||||||||||||||||||||| ||||| 
Sbjct  911   NTTGGATTTGCTNNCGAAAATGTTAATCTATGATCCAGCCAAACGAATTTCTGGNAAAAT  970 
 
Query  840   GGCACTGAATCATCCATATTTTAATGATTTGGACAATCAGATTAA  884 
             ||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  971   GGCACTGAATCATCCATATTTTAATGATTTGGACAATCAGATTAA  1015 
 
 
Results of BLAST search for CDK1 AF cloned into pEXP32, RW: 
>lcl|34167  
Length=982 
 
 Score = 1550 bits (839),  Expect = 0.0 
 Identities = 856/871 (98%), Gaps = 0/871 (0%) 
 Strand=Plus/Minus 
 
Query  24   GAAAATTGGAGAAGGTACCTATGGAGTTGTGTATAAGGGTAGACACAAAACTACAGGTCA  83 
            |||||||||  ||||| ||| |||||||      |||||||||||||||||  ||||||| 
Sbjct  981  GAAAATTGGNNAAGGTGCCTTTGGAGTTNNNNNNAAGGGTAGACACAAAACNNCAGGTCA  922 
   
Query  84   AGTGGTAGCCATGaaaaaaaTCAGACTAGAAAGTGAAGAGGAAGGGGTTCCTAGTACTGC  143 
            |||||||||||||||||||||  ||||||||||||||||||||||||||||||||||||| 
Sbjct  921  AGTGGTAGCCATGAAAAAAATNNGACTAGAAAGTGAAGAGGAAGGGGTTCCTAGTACTGC  862 
 
Query  144  AATTCGGGAAATTTCTCTATTAAAGGAACTTCGTCATCCAAATATAGTCAGTCTTCAGGA  203 
            |||||||||||||| ||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  861  AATTCGGGAAATTTNTCTATTAAAGGAACTTCGTCATCCAAATATAGTCAGTCTTCAGGA  802 
 
Query  204  TGTGCTTATGCAGGATTCCAGGTTATATCTCATCTTTGAGTTTCTTTCCATGGATCTGAA  263 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  801  TGTGCTTATGCAGGATTCCAGGTTATATCTCATCTTTGAGTTTCTTTCCATGGATCTGAA  742 
 
Query  264  GAAATACTTGGATTCTATCCCTCCTGGTCAGTACATGGATTCTTCACTTGTTAAGAGTTA  323 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  741  GAAATACTTGGATTCTATCCCTCCTGGTCAGTACATGGATTCTTCACTTGTTAAGAGTTA  682 
 
Query  324  TTTATACCAAATCCTACAGGGGATTGTGTTTTGTCACTCTAGAAGAGTTCTTCACAGAGA  383 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
  - 86 - 
Sbjct  681  TTTATACCAAATCCTACAGGGGATTGTGTTTTGTCACTCTAGAAGAGTTCTTCACAGAGA  622 
 
Query  384  CTTAAAACCTCAAAATCTCTTGATTGATGACAAAGGAACAATTAAACTGGCTGATTTTGG  443 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  621  CTTAAAACCTCAAAATCTCTTGATTGATGACAAAGGAACAATTAAACTGGCTGATTTTGG  562 
 
Query  444  CCTTGCCAGAGCTTTTGGAATACCTATCAGAGTATATACACATGAGGTAGTAACACTCTG  503 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  561  CCTTGCCAGAGCTTTTGGAATACCTATCAGAGTATATACACATGAGGTAGTAACACTCTG  502 
 
Query  504  GTACAGATCTCCAGAAGTATTGCTGGGGTCAGCTCGTTACTCAACTCCAGTTGACATTTG  563 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  501  GTACAGATCTCCAGAAGTATTGCTGGGGTCAGCTCGTTACTCAACTCCAGTTGACATTTG  442 
 
Query  564  GAGTATAGGCACCATATTTGCTGAACTAGCAACTAAGAAACCACTTTTCCATGGGGATTC  623 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  441  GAGTATAGGCACCATATTTGCTGAACTAGCAACTAAGAAACCACTTTTCCATGGGGATTC  382 
 
Query  624  AGAAATTGATCAACTCTTCAGGATTTTCAGAGCTTTGGGCACTCCCAATAATGAAGTGTG  683 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  381  AGAAATTGATCAACTCTTCAGGATTTTCAGAGCTTTGGGCACTCCCAATAATGAAGTGTG  322 
 
Query  684  GCCAGAAGTGGAATCTTTACAGGACTATAAGAATACATTTCCCAAATGGAAACCAGGAAG  743 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  321  GCCAGAAGTGGAATCTTTACAGGACTATAAGAATACATTTCCCAAATGGAAACCAGGAAG  262 
 
Query  744  CCTAGCATCCCATGTCAAAAACTTGGATGAAAATGGCTTGGATTTGCTCTCGAAAATGTT  803 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  261  CCTAGCATCCCATGTCAAAAACTTGGATGAAAATGGCTTGGATTTGCTCTCGAAAATGTT  202 
 
Query  804  AATCTATGATCCAGCCAAACGAATTTCTGGCAAAATGGCACTGAATCATCCATATTTTAA  863 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  201  AATCTATGATCCAGCCAAACGAATTTCTGGCAAAATGGCACTGAATCATCCATATTTTAA  142 
 
Query  864  TGATTTGGACAATCAGATTAAGAAGATGTAG  894 
            ||||||||||||||||||||||||||||||| 
Sbjct  141  TGATTTGGACAATCAGATTAAGAAGATGTAG  111 
 
 
 
 
Results of BLAST search for CDK2 AF cloned into pEXP32, FW: #9 
>lcl|37315  
Length=1012 
 
 Score = 1620 bits (877),  Expect = 0.0 
 Identities = 884/888 (99%), Gaps = 0/888 (0%) 
 Strand=Plus/Plus 
 
Query  1     ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCACGTACGGAGTTGTGTACAAA  60 
             ||||||||||||||||||||||||||||||||||||||| | | |||||||||||||||| 
Sbjct  125   ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCGCCTTCGGAGTTGTGTACAAA  184 
 
Query  61    GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  185   GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  244 
 
Query  121   ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  245   ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  304 
 
Query  181   CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  305   CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  364 
 
Query  241   GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  365   GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  424 
 
Query  301   CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  425   CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  484 
 
  - 87 - 
Query  361   CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  485   CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  544 
 
Query  421   ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  545   ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  604 
 
Query  481   CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  605   CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  664 
 
Query  541   TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  665   TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  724 
 
Query  601   GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  725   GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  784 
 
Query  661   ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  785   ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  844 
 
Query  721   CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGATGAAGATGGACGG  780 
             ||||||||||||||||||||||||||||||||||||||||||||||| |||||||||||| 
Sbjct  845   CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGANGAAGATGGACGG  904 
 
Query  781   AGCTTGTTATCGCAAATGCTGCACTACGACCCTAACAAGCGGATTTCGGCCAAGGCAGCC  840 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  905   AGCTTGTTATCGCAAATGCTGCACTACGACCCTAACAAGCGGATTTCGGCCAAGGCAGCC  964 
 
Query  841   CTGGCTCACCCTTTCTTCCAGGATGTGACCAAGCCAGTACCCCATCTT  888 
             |||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  965   CTGGCTCACCCTTTCTTCCAGGATGTGACCAAGCCAGTACCCCATCTT  1012 
 
 
 
Result of BLAST search for CDK2 AF cloned into pEXP32, RW: 
>lcl|39983  
Length=1069 
 
 Score = 1637 bits (886),  Expect = 0.0 
 Identities = 893/897 (99%), Gaps = 0/897 (0%) 
 Strand=Plus/Minus 
 
Query  1     ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCACGTACGGAGTTGTGTACAAA  60 
             ||||||||||||||||||||||||||||||||||||||| | |  ||||||||||||||| 
Sbjct  1009  ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCGCCTTNGGAGTTGTGTACAAA  950 
 
Query  61    GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  949   GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  890 
 
Query  121   ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  889   ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  830 
 
Query  181   CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  829   CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  770 
 
Query  241   GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  769   GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  710 
 
Query  301   CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  709   CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  650 
 
Query  361   CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  649   CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  590 
 
  - 88 - 
Query  421   ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  589   ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  530 
 
Query  481   CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  529   CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  470 
 
Query  541   TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  469   TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  410 
 
Query  601   GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  409   GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  350 
 
Query  661   ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  349   ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  290 
 
Query  721   CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGATGAAGATGGACGG  780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  289   CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGATGAAGATGGACGG  230 
 
Query  781   AGCTTGTTATCGCAAATGCTGCACTACGACCCTAACAAGCGGATTTCGGCCAAGGCAGCC  840 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  229   AGCTTGTTATCGCAAATGCTGCACTACGACCCTAACAAGCGGATTTCGGCCAAGGCAGCC  170 
 
Query  841   CTGGCTCACCCTTTCTTCCAGGATGTGACCAAGCCAGTACCCCATCTTCGACTCTGA  897 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  169   CTGGCTCACCCTTTCTTCCAGGATGTGACCAAGCCAGTACCCCATCTTCGACTCTGA  113 
 
 
 
Results of BLAST search for CDK2 AF cloned into pEXP32, FW: #10 
>lcl|15595  
Length=1024 
 
 Score = 1572 bits (851),  Expect = 0.0 
 Identities = 879/893 (98%), Gaps = 7/893 (1%) 
 Strand=Plus/Plus 
 
Query  1     ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCACGTACGGAGTTGTGTACAAA  60 
             ||||||||||||||||||||||||||||||||||||||| | | |||||||||||||||| 
Sbjct  132   ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCGCCTTCGGAGTTGTGTACAAA  191 
 
Query  61    GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  192   GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  251 
 
Query  121   ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  252   ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  311 
 
Query  181   CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  312   CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  371 
 
Query  241   GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  372   GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  431 
 
Query  301   CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  432   CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  491 
 
Query  361   CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  492   CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  551 
 
Query  421   ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  552   ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  611 
 
  - 89 - 
Query  481   CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  612   CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  671 
 
Query  541   TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  672   TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  731 
 
Query  601   GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  732   GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  791 
 
Query  661   ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  792   ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  851 
 
Query  721   CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGATGAAGATGGACGG  780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  852   CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGATGAAGATGGACGG  911 
 
Query  781   A-GCTTGTTATCGCAAATGCTGCACTACGACCCTAAC-AAGCGGATTTCGGCCAAGGCAG  838 
             | ||||||||||||||||||||||||||||||||||  |||||||||||||||||||||| 
Sbjct  912   AAGCTTGTTATCGCAAATGCTGCACTACGACCCTAANNAAGCGGATTTCGGCCAAGGCAG  971 
 
Query  839   CCCTGGC-TCACCCTTT-CTTCCAGG-ATGTGACCAAGCC-AGTACCCC-ATC  886 
             ||||||| ||||||||| |||||    ||||||||||||| |||||||| ||| 
Sbjct  972   CCCTGGCCTCACCCTTTTCTTCCNNNNATGTGACCAAGCCCAGTACCCCCATC  1024 
 
 
 
Results of BLAST search for CDK2 AF cloned into pEXP32, RW: 
>lcl|17759  
Length=1109 
 
 Score = 1640 bits (888),  Expect = 0.0 
 Identities = 894/897 (99%), Gaps = 0/897 (0%) 
 Strand=Plus/Minus 
 
Query  1     ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCACGTACGGAGTTGTGTACAAA  60 
             ||||||||||||||||||||||||||||||||||||||| | | |||||||||||||||| 
Sbjct  1013  ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCGCCTTCGGAGTTGTGTACAAA  954 
 
Query  61    GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  953   GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  894 
 
Query  121   ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  893   ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  834 
 
Query  181   CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  833   CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  774 
 
Query  241   GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  773   GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  714 
 
Query  301   CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  713   CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  654 
 
Query  361   CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  653   CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  594 
 
Query  421   ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  593   ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  534 
 
Query  481   CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  533   CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  474 
 
  - 90 - 
Query  541   TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  473   TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  414 
 
Query  601   GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  413   GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  354 
 
Query  661   ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  353   ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  294 
 
Query  721   CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGATGAAGATGGACGG  780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  293   CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGATGAAGATGGACGG  234 
 
Query  781   AGCTTGTTATCGCAAATGCTGCACTACGACCCTAACAAGCGGATTTCGGCCAAGGCAGCC  840 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  233   AGCTTGTTATCGCAAATGCTGCACTACGACCCTAACAAGCGGATTTCGGCCAAGGCAGCC  174 
 
Query  841   CTGGCTCACCCTTTCTTCCAGGATGTGACCAAGCCAGTACCCCATCTTCGACTCTGA  897 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  173   CTGGCTCACCCTTTCTTCCAGGATGTGACCAAGCCAGTACCCCATCTTCGACTCTGA  117 
 
 
 
Result of BLAST search for CKS2 cloned into pEXP22, FW: 
Query: CKS2 
Subject: pEXP22-CKSA FW 
 
>lcl|21587  
Length=905 
 
 Score =  444 bits (240),  Expect = 4e-129 
 Identities = 240/240 (100%), Gaps = 0/240 (0%) 
 Strand=Plus/Plus 
 
Query  1    ATGGCCCACAAGCAGATCTACTACTCGGACAAGTACTTCGACGAACACTACGAGTACCGG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  130  ATGGCCCACAAGCAGATCTACTACTCGGACAAGTACTTCGACGAACACTACGAGTACCGG  189 
 
Query  61   CATGTTATGTTACCCAGAGAACTTTCCAAACAAGTACCTAAAACTCATCTGATGTCTGAA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  190  CATGTTATGTTACCCAGAGAACTTTCCAAACAAGTACCTAAAACTCATCTGATGTCTGAA  249 
 
Query  121  GAGGAGTGGAGGAGACTTGGTGTCCAACAGAGTCTAGGCTGGGTTCATTACATGATTCAT  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  250  GAGGAGTGGAGGAGACTTGGTGTCCAACAGAGTCTAGGCTGGGTTCATTACATGATTCAT  309 
 
Query  181  GAGCCAGAACCACATATTCTTCTCTTTAGACGACCTCTTCCAAAAGATCAACAAAAATGA  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  310  GAGCCAGAACCACATATTCTTCTCTTTAGACGACCTCTTCCAAAAGATCAACAAAAATGA  369 
 
 
 
Results of BLAST search for CDK1 AF cloned into pEXP22, FW: 
>lcl|18249  
Length=934 
 
 Score = 1483 bits (803),  Expect = 0.0 
 Identities = 810/815 (99%), Gaps = 0/815 (0%) 
 Strand=Plus/Plus 
 
Query  1    ATGGAAGATTATACCAAAATAGAGAAAATTGGAGAAGGTACCTATGGAGTTGTGTATAAG  60 
            ||||||||||||||||||||||||||||||||||||||| ||| |||||||||||||||| 
Sbjct  115  ATGGAAGATTATACCAAAATAGAGAAAATTGGAGAAGGTGCCTTTGGAGTTGTGTATAAG  174 
 
Query  61   GGTAGACACAAAACTACAGGTCAAGTGGTAGCCATGaaaaaaaTCAGACTAGAAAGTGAA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  175  GGTAGACACAAAACTACAGGTCAAGTGGTAGCCATGAAAAAAATCAGACTAGAAAGTGAA  234 
  - 91 - 
 
Query  121  GAGGAAGGGGTTCCTAGTACTGCAATTCGGGAAATTTCTCTATTAAAGGAACTTCGTCAT  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  235  GAGGAAGGGGTTCCTAGTACTGCAATTCGGGAAATTTCTCTATTAAAGGAACTTCGTCAT  294 
 
Query  181  CCAAATATAGTCAGTCTTCAGGATGTGCTTATGCAGGATTCCAGGTTATATCTCATCTTT  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  295  CCAAATATAGTCAGTCTTCAGGATGTGCTTATGCAGGATTCCAGGTTATATCTCATCTTT  354 
 
Query  241  GAGTTTCTTTCCATGGATCTGAAGAAATACTTGGATTCTATCCCTCCTGGTCAGTACATG  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  355  GAGTTTCTTTCCATGGATCTGAAGAAATACTTGGATTCTATCCCTCCTGGTCAGTACATG  414 
 
Query  301  GATTCTTCACTTGTTAAGAGTTATTTATACCAAATCCTACAGGGGATTGTGTTTTGTCAC  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  415  GATTCTTCACTTGTTAAGAGTTATTTATACCAAATCCTACAGGGGATTGTGTTTTGTCAC  474 
 
Query  361  TCTAGAAGAGTTCTTCACAGAGACTTAAAACCTCAAAATCTCTTGATTGATGACAAAGGA  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  475  TCTAGAAGAGTTCTTCACAGAGACTTAAAACCTCAAAATCTCTTGATTGATGACAAAGGA  534 
 
Query  421  ACAATTAAACTGGCTGATTTTGGCCTTGCCAGAGCTTTTGGAATACCTATCAGAGTATAT  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  535  ACAATTAAACTGGCTGATTTTGGCCTTGCCAGAGCTTTTGGAATACCTATCAGAGTATAT  594 
 
Query  481  ACACATGAGGTAGTAACACTCTGGTACAGATCTCCAGAAGTATTGCTGGGGTCAGCTCGT  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  595  ACACATGAGGTAGTAACACTCTGGTACAGATCTCCAGAAGTATTGCTGGGGTCAGCTCGT  654 
 
Query  541  TACTCAACTCCAGTTGACATTTGGAGTATAGGCACCATATTTGCTGAACTAGCAACTAAG  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  655  TACTCAACTCCAGTTGACATTTGGAGTATAGGCACCATATTTGCTGAACTAGCAACTAAG  714 
 
Query  601  AAACCACTTTTCCATGGGGATTCAGAAATTGATCAACTCTTCAGGATTTTCAGAGCTTTG  660 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  715  AAACCACTTTTCCATGGGGATTCAGAAATTGATCAACTCTTCAGGATTTTCAGAGCTTTG  774 
 
Query  661  GGCACTCCCAATAATGAAGTGTGGCCAGAAGTGGAATCTTTACAGGACTATAAGAATACA  720 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  775  GGCACTCCCAATAATGAAGTGTGGCCAGAAGTGGAATCTTTACAGGACTATAAGAATACA  834 
 
Query  721  TTTCCCAAATGGAAACCAGGAAGCCTAGCATCCCATGTCAAAAACTTGGATGAAAATGGC  780 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  835  TTTCCCAAATGGAAACCAGGAAGCCTAGCATCCCATGTCAAAAACTTGGATGAAAATGGC  894 
 
Query  781  TTGGATTTGCTCTCGAAAATGTTAATCTATGATCC  815 
            |||||||||||  | |||||||||||||||||||| 
Sbjct  895  TTGGATTTGCTNNCNAAAATGTTAATCTATGATCC  929 
 
 
 
Result of BLAST search for CDK1 AF cloned into pEXP22, RW: 
>lcl|44275  
Length=975 
 
 Score = 1493 bits (808),  Expect = 0.0 
 Identities = 813/818 (99%), Gaps = 0/818 (0%) 
 Strand=Plus/Minus 
 
Query  77   CAGGTCAAGTGGTAGCCATGaaaaaaaTCAGACTAGAAAGTGAAGAGGAAGGGGTTCCTA  136 
            ||||||||||||||||||||||||||||  | |||||||||||||||||||||||||||| 
Sbjct  924  CAGGTCAAGTGGTAGCCATGAAAAAAATNNGNCTAGAAAGTGAAGAGGAAGGGGTTCCTA  865 
 
Query  137  GTACTGCAATTCGGGAAATTTCTCTATTAAAGGAACTTCGTCATCCAAATATAGTCAGTC  196 
            ||||||||||||||||||||| | |||||||||||||||||||||||||||||||||||| 
Sbjct  864  GTACTGCAATTCGGGAAATTTNTNTATTAAAGGAACTTCGTCATCCAAATATAGTCAGTC  805 
 
Query  197  TTCAGGATGTGCTTATGCAGGATTCCAGGTTATATCTCATCTTTGAGTTTCTTTCCATGG  256 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  804  TTCAGGATGTGCTTATGCAGGATTCCAGGTTATATCTCATCTTTGAGTTTCTTTCCATGG  745 
 
Query  257  ATCTGAAGAAATACTTGGATTCTATCCCTCCTGGTCAGTACATGGATTCTTCACTTGTTA  316 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  744  ATCTGAAGAAATACTTGGATTCTATCCCTCCTGGTCAGTACATGGATTCTTCACTTGTTA  685 
  - 92 - 
 
Query  317  AGAGTTATTTATACCAAATCCTACAGGGGATTGTGTTTTGTCACTCTAGAAGAGTTCTTC  376 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  684  AGAGTTATTTATACCAAATCCTACAGGGGATTGTGTTTTGTCACTCTAGAAGAGTTCTTC  625 
 
Query  377  ACAGAGACTTAAAACCTCAAAATCTCTTGATTGATGACAAAGGAACAATTAAACTGGCTG  436 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  624  ACAGAGACTTAAAACCTCAAAATCTCTTGATTGATGACAAAGGAACAATTAAACTGGCTG  565 
 
Query  437  ATTTTGGCCTTGCCAGAGCTTTTGGAATACCTATCAGAGTATATACACATGAGGTAGTAA  496 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  564  ATTTTGGCCTTGCCAGAGCTTTTGGAATACCTATCAGAGTATATACACATGAGGTAGTAA  505 
 
Query  497  CACTCTGGTACAGATCTCCAGAAGTATTGCTGGGGTCAGCTCGTTACTCAACTCCAGTTG  556 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  504  CACTCTGGTACAGATCTCCAGAAGTATTGCTGGGGTCAGCTCGTTACTCAACTCCAGTTG  445 
 
Query  557  ACATTTGGAGTATAGGCACCATATTTGCTGAACTAGCAACTAAGAAACCACTTTTCCATG  616 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  444  ACATTTGGAGTATAGGCACCATATTTGCTGAACTAGCAACTAAGAAACCACTTTTCCATG  385 
 
Query  617  GGGATTCAGAAATTGATCAACTCTTCAGGATTTTCAGAGCTTTGGGCACTCCCAATAATG  676 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  384  GGGATTCAGAAATTGATCAACTCTTCAGGATTTTCAGAGCTTTGGGCACTCCCAATAATG  325 
 
Query  677  AAGTGTGGCCAGAAGTGGAATCTTTACAGGACTATAAGAATACATTTCCCAAATGGAAAC  736 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  324  AAGTGTGGCCAGAAGTGGAATCTTTACAGGACTATAAGAATACATTTCCCAAATGGAAAC  265 
 
Query  737  CAGGAAGCCTAGCATCCCATGTCAAAAACTTGGATGAAAATGGCTTGGATTTGCTCTCGA  796 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  264  CAGGAAGCCTAGCATCCCATGTCAAAAACTTGGATGAAAATGGCTTGGATTTGCTCTCGA  205 
 
Query  797  AAATGTTAATCTATGATCCAGCCAAACGAATTTCTGGCAAAATGGCACTGAATCATCCAT  856 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  204  AAATGTTAATCTATGATCCAGCCAAACGAATTTCTGGCAAAATGGCACTGAATCATCCAT  145 
 
Query  857  ATTTTAATGATTTGGACAATCAGATTAAGAAGATGTAG  894 
            |||||||||||||||||||||||||||||||||||||| 
Sbjct  144  ATTTTAATGATTTGGACAATCAGATTAAGAAGATGTAG  107 
 
 
 
Result of BLAST search for CDK2 AF cloned into pEXP22, FW: 
>lcl|51541  
Length=908 
 
 Score = 1428 bits (773),  Expect = 0.0 
 Identities = 784/791 (99%), Gaps = 0/791 (0%) 
 Strand=Plus/Plus 
 
Query  1    ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCACGTACGGAGTTGTGTACAAA  60 
            ||||||||||||||||||||||||||||||||||||||| | | |||||||||||||||| 
Sbjct  118  ATGGAGAACTTCCAAAAGGTGGAAAAGATCGGAGAGGGCGCCTTCGGAGTTGTGTACAAA  177 
 
Query  61   GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  178  GCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAATCCGCCTGGACACTGAG  237 
 
Query  121  ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  238  ACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCTTAAGGAGCTTAACCAT  297 
 
Query  181  CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  298  CCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAAACTCTACCTGGTTTTT  357 
 
Query  241  GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  358  GAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGCTCTCACTGGCATTCCT  417 
 
Query  301  CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  418  CTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCTAGCTTTCTGCCATTCT  477 
  - 93 - 
 
Query  361  CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  478  CATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTATTAACACAGAGGGGGCC  537 
 
Query  421  ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  538  ATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCCTGTTCGTACTTACACC  597 
 
Query  481  CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  598  CATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCTGGGCTGCAAATATTAT  657 
 
Query  541  TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  658  TCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGAGATGGTGACTCGCCGG  717 
 
Query  601  GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  660 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  718  GCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGATCTTTCGGACTCTGGGG  777 
 
Query  661  ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  720 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  778  ACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGATTACAAGCCAAGTTTC  837 
 
Query  721  CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGATGAAGATGGACGG  780 
            |||||||||||||||||||||||||||||||||||||||||||||||  || |||||||| 
Sbjct  838  CCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCTGGANNAANATGGACGG  897 
 
Query  781  AGCTTGTTATC  791 
            | ||||||||| 
Sbjct  898  AACTTGTTATC  908 
 
 
 
Result of BLAST search for CDK2 AF cloned into pEXP22, RW: 
>lcl|29011  
Length=977 
 
 Score = 1557 bits (843),  Expect = 0.0 
 Identities = 848/853 (99%), Gaps = 0/853 (0%) 
 Strand=Plus/Minus 
 
Query  45   CGGAGTTGTGTACAAAGCCAGAAACAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAAT  104 
            ||||||| | ||||||||||||| |||||||||||||||||||||||||||||||||||| 
Sbjct  964  CGGAGTTNTNTACAAAGCCAGAANCAAGTTGACGGGAGAGGTGGTGGCGCTTAAGAAAAT  905 
 
Query  105  CCGCCTGGACACTGAGACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCTCTCTGCT  164 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||  |||||| 
Sbjct  904  CCGCCTGGACACTGAGACTGAGGGTGTGCCCAGTACTGCCATCCGAGAGATCNNTCTGCT  845 
 
Query  165  TAAGGAGCTTAACCATCCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAA  224 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  844  TAAGGAGCTTAACCATCCTAATATTGTCAAGCTGCTGGATGTCATTCACACAGAAAATAA  785 
 
Query  225  ACTCTACCTGGTTTTTGAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGC  284 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  784  ACTCTACCTGGTTTTTGAATTTCTGCACCAAGATCTCAAGAAATTCATGGATGCCTCTGC  725 
 
Query  285  TCTCACTGGCATTCCTCTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCT  344 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  724  TCTCACTGGCATTCCTCTTCCCCTCATCAAGAGCTATCTGTTCCAGCTGCTCCAGGGCCT  665 
 
Query  345  AGCTTTCTGCCATTCTCATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTAT  404 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  664  AGCTTTCTGCCATTCTCATCGGGTCCTCCACCGAGACCTTAAACCTCAGAATCTGCTTAT  605 
 
Query  405  TAACACAGAGGGGGCCATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCC  464 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  604  TAACACAGAGGGGGCCATCAAGCTAGCAGACTTTGGACTAGCCAGAGCTTTTGGAGTCCC  545 
 
Query  465  TGTTCGTACTTACACCCATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCT  524 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  544  TGTTCGTACTTACACCCATGAGGTGGTGACCCTGTGGTACCGAGCTCCTGAAATCCTCCT  485 
  - 94 - 
 
Query  525  GGGCTGCAAATATTATTCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGA  584 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  484  GGGCTGCAAATATTATTCCACAGCTGTGGACATCTGGAGCCTGGGCTGCATCTTTGCTGA  425 
 
Query  585  GATGGTGACTCGCCGGGCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGAT  644 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  424  GATGGTGACTCGCCGGGCCCTATTCCCTGGAGATTCTGAGATTGACCAGCTCTTCCGGAT  365 
 
Query  645  CTTTCGGACTCTGGGGACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGA  704 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  364  CTTTCGGACTCTGGGGACCCCAGATGAGGTGGTGTGGCCAGGAGTTACTTCTATGCCTGA  305 
 
Query  705  TTACAAGCCAAGTTTCCCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCT  764 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  304  TTACAAGCCAAGTTTCCCCAAGTGGGCCCGGCAAGATTTTAGTAAAGTTGTACCTCCCCT  245 
 
Query  765  GGATGAAGATGGACGGAGCTTGTTATCGCAAATGCTGCACTACGACCCTAACAAGCGGAT  824 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  244  GGATGAAGATGGACGGAGCTTGTTATCGCAAATGCTGCACTACGACCCTAACAAGCGGAT  185 
 
Query  825  TTCGGCCAAGGCAGCCCTGGCTCACCCTTTCTTCCAGGATGTGACCAAGCCAGTACCCCA  884 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  184  TTCGGCCAAGGCAGCCCTGGCTCACCCTTTCTTCCAGGATGTGACCAAGCCAGTACCCCA  125 
 
Query  885  TCTTCGACTCTGA  897 
            ||||||||||||| 
Sbjct  124  TCTTCGACTCTGA  112 
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Appendix 18 
 
Working plate of S. cerevisiae MaV203 
 
 
1) Use a micropipette-tip to transfer and resuspend an appropriate amount of S. cerevisiae 
MaV203 from the -80 °C glycerol stock in 1000 µl sterile 0.8 % NaCl.  
2) Plate 100 μl of serial dilutions (10-2, 10-3, 10-4 and 10-5) onto YPD agar  
(appendix 21) supplemented with adenine hemi sulfate to a final concentration of 100 μg/ml 
(YPAD). 
3) Let dry before incubation at 30 °C for 3-4 days. 
4) The working plates can be stored at 4 °C for 4-6 weeks.  
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Appendix 19 
 
Protocol for transformation in S. cerevisiae MaV203 by the 
Lithium Acetate/single-stranded carrier DNA/polyethylene glycol method  
(LiAc/SS carrier DNA/PEG) 
(one-step method) 
 
 
1) Mix 100 µl of one-step buffer with 10 µl of sterile 1 M dithiothreitol (DTT). 
2) Harvest and resuspend 3 colonies of S. cerevisiae MaV203 from the working plate  
(size: 2-3 mm) in this solution by vortexing. 
3) Add this mix in a microcentrifuge tube containing ~ 500 ng of each plasmid DNA (the total 
volume of DNA should be up to 10 µl and approximately 1 µg) and 1µl Herring Testes 
Carrier DNA.  
4) Vortex gently. 
5) Incubate at 45 °C for 30 minutes. 
6) Plate the cells on solid SC -leu-trp medium (appendix 21). Use glassbeads to promote even 
spreading of the cells. 
7) Incubate the plates at 30 °C for 3-5 days.  
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Appendix 20 
 
Protocol for S. cerevisiae MaV203 two-hybrid analysis 
 
Day 1. Preparation of S. cerevisiae MaV203 overnight culture: 
 
Add the following to separate Falcon tubes:  
2 ml SD-DO medium (-ade -his -leu -trp)  
Adenine hemisulfate to a final concentration of 20 µg/ml  
L-histidine to a final concentration of 125 µg/ml 
 
Transfer one S. cerevisiae MaV203 transformant per separate Falcon tube. Incubate at 
30 °C overnight in a shaking water bath. 
 
Day 2. 
1) Centrifuge 1.5 ml from the overnight culture at 16400 rpm for 3 minutes, and discharge the 
supernatant. 
2) Resuspend the cell pellet in 1 ml sterile 0.8 % NaCl. Centrifuge at 16400 rpm for 3 minutes 
and discharge the supernatant. 
3) Repeat step 3. 
4) Resuspend the cell pellet in 500 µl sterile 0.8 % NaCl. 
5) Dilute 100 µl from step 4 with 900 μl of sterile 0.8 % NaCl, and measure optical density 
(OD) at 600 nm. Adjust with sterile 0.8 % NaCl to OD ~ 1.0. 
6) Prepare 10-1, 10-2, and 10-3 dilutions with sterile 0.8 % NaCl for each sample. 
7) Spot 10 μl aliquots of each dilution (OD = 1, 10-1, 10-2, 10-3) onto agar selection plates with 
a marked-up grid.  
8) Let dry, and incubate at 30 °C for 3 days. 
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Appendix 21 
 
Recipes 
 
Luria-Bertani (LB) Medium, Agar and Plates 
 
Rich medium for growth of E. coli 
 
LB medium: 
Bacto tryptone   10 g 
Yeast extract      5 g 
NaCl     10 g 
dH2O        to 1000 ml  
Sterilize by autoclaving: 121° C, 15 min 
 
LB agar: 
Bacto agar    20 g 
Yeast extract      5 g 
NaCl     10 g 
Bacto tryptone   10 g 
dH2O        to 1000 ml 
Sterilize by autoclaving: 121° C, 15 min 
 
LB agar plates: 
Melt LB agar in microwave. Cool to ~55 °C, add appropriate antibiotic*. Dispense into sterile 
10 cm petri dishes. Store plates when solidified upside down at 4 °C. 
 
*  Plasmid   Antibiotic resistance gene Concentration, µg/ml 
     pGBKT7   Kanamycin   50 
     pGADT7   Ampicillin   100 
     pENTR™/D-TOPO®  Kanamycin    50  
     pDEST
TM
32   Gentamicin   2  
     pDEST
TM
22   Ampicillin   100  
 
 
YPD Medium, Agar and Plates: 
 
Rich medium for growth of S. cerevisiae 
 
YPD medium 
YPD              25 g 
dH2O      to 500 ml 
Sterilize by autoclaving: 121° C, 15 min 
 
YPD agar 
YPD               20 g 
dH2O to 300 ml and let it dissolve under stirring 
Adjust pH to 5.9 – 6.2  
Bacto agar              9 g 
dH2O     to 400 ml 
Sterilize by autoclaving: 121° C, 15 min 
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YPAD plates 
Melt YPD agar in microwave. Cool to ~55 °C, add adenine sulfate to a final concentration of 
100 µg/ml. Dispense into sterile 10 cm petri dishes. Store plates when solidified upside down at 
4 °C. 
 
 
SC Medium, Agar and Plates: 
 
Synthetic Complete medium for growth of S. cerevisiae. 
 
Syntetic complete consists of a nitrogen base, a carbon source, and a ‘dropout’ solution containing 
essential aminoacids, nucleic acids, trace elements and vitamins. For selection purposes, certain 
amino acids are omitted (‘dropped out’) from the medium.  
 
SC medium 
Minimal SD base    10.68 g 
DO supplement (-his -leu -trp -ura)   0.24 g 
dH2O              to 500 ml 
Sterilize by autoclaving: 121 °C, 15 min 
 
SC agar 
Minimal SD base    10.68 g 
DO supplement (-his -leu -trp -ura)   0.24 g 
Adjust pH to 5.9 – 6.2  
Bacto agar           9 g 
dH2O              to 400 ml 
Sterilize by autoclaving: 121 °C, 15 min 
 
SC plates 
Melt SC agar in microwave, Cool to ~55 °C, add appropriate supplements (see table below). 
Dispense into sterile 10 cm petri dishes. Store plates when solidified upside down at 4 °C. 
 
Selection plate Added supplement(s) Purpose/assay 
Sc -leu-trp 
 
20 µg/ml uracil 
125 µg/ml L-histidine 
Transformation control  
Sc –leu-trp-his + 10 mM 3-AT 20 µg/ml uracil 
10 mM 3-AT 
HIS3 activation (positive selection) 
Sc -leu-trp-ura 
 
125 µg/ml L-histidine URA3 activation (positive selection) 
Sc -leu-trp + 5-FOA* 
 
20 µg/ml uracil 
125 µg/ml L-histidine 
0.2 % 5-FOA 
URA3 activation (negative selection) 
* see direction for preparation below 
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Medium, Agar and Plates for the 5-FOA test: 
 
2xSC medium 
Minimal SD base   26.70 g 
DO supplement (-his -leu -trp -ura)   0.60 g 
dH2O to 300 ml and let it dissolve under stirring 
Adjust pH 5.9 – 6.2 
Complete with dH2O                       to 400 ml 
Sterilize by autoclaving: 121 °C, 15 min 
 
4 % agar: 
Bacto agar         16 g 
dH2O                     to 400 ml 
Sterilize by autoclaving: 121 °C, 15 min 
 
5-FOA plates: 
Heat 2xSC medium to ~ 55 °C  
Add 5-FOA to a final concentration of 0.2 % 
Adjust pH~4.5 
Combine with equal amount melted 4 % agar (cooled down to ~ 55 °C)  
Dispense into sterile 10 cm petri dishes. Store plates when solidified upside down at 4 °C 
 
 
Other solutions: 
 
 
0.8 % NaCl 
Sodium chloride   4 g 
dH2O         to 500 µl 
 
 
10x loading buffer: 
Glycerol, 87 %   500 µl 
dH2O     500 µl 
Bromophenol blue   0.03 %*  
 
*add appropriate amount until a deep blue color is achieved 
 
For preparation of 1x loading buffer: dilute 1:10. 
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Appendix 22 
 
List of materials used 
 
 
Materials and  
reagents used for Y2H  Relevant features    Source 
MaV203    MATα, leu2-3,112, trp1-901, his3Δ200,   Invitrogen 
ade2-101, gal4Δ, gal80Δ, SPAL10::URA3,  
GAL1::lacZ, HIS3UAS GAL1::HIS3@LYS2,  
can1
R
, cyh2
R
 
Bacto agar         BD 
DO supplement         Clontech 
Herring Testes Carrier DNA        Clontech 
Minimal SD base         Clontech 
YPD          Clontech 
5-FOA          Fermentas 
 
Bacterial strains   Genotype     Source 
TOP10 One Shot   F
- 
mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15  Invitrogen 
ΔlacΧ74 recA1 araD139 Δ(ara-leu) 7697 galU  
galK rpsL (Str
R
) endA1 nupG λ- 
 
XL 10-Gold   Tet
rΔ(mrcA)183Δ(mrcCB-hsdSMR-mrr)173  Stratagene 
endA1 supE44 thi-1 recA1 gyrA96 relA1 lac Hte 
[F´ proAB lac1
q
Z ΔM15 Tn10 (Tetr) Amy Camr] 
  
 
Nutritional/ 
selection 
Plasmids   Relevant features  marker  Source 
pGBKT7    PADH1, pUC ori, 2 μ ori;  Kan/ TRP1 Clontech  
    yeast two-hybrid vector    
bearing the GAL4 DNA binding  
domain 
 
pGBK/CKS2    pGBKT7 bearing CKS2   Kan/ TRP1  Irene Sunnvoll 
 
pGBK/CDK1AF   pGBKT7 bearing CDK1AF Kan/ TRP1  Irene Sunnvoll 
 
pGBK/CDK2AF   pGBKT7 bearing CDK2AF  Kan/ TRP1 Irene Sunnvoll 
 
pGADT7   PADH1, pUC ori, 2 μ ori;  Amp/ LEU2 Clontech  
    yeast two-hybrid vector    
bearing the GAL4 AD binding  
domain 
 
pGAD/CKS2   pGADT7 bearing CKS2  Amp/ LEU2 Irene Sunnvoll 
 
pGAD/CDK1 AF   pGADT7 bearing CDK1 AF Amp/ LEU2 Irene Sunnvoll 
 
pGAD/CDK2 AF   pGADT7 bearing CDK2 AF Amp/ LEU2 Irene Sunnvoll 
 
pENTR™/D-TOPO®  pUC ori, attL1, TOPO   Kan  Invitrogen 
recognition site 1, attL2, 
TOPO recognition site 2 
 
pENTR/CKS2   pENTR™/D-TOPO® bearing Kan  This work  
    CKS2 
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pENTR/CDK1 AF  pENTR™/D-TOPO® bearing Kan  This work 
    CDK1 AF 
 
pENTR/CDK2 AF  pENTR™/D-TOPO® bearing Kan  This work 
    CDK2 AF 
 
pDEST
TM
32   PADH1, pUC ori, ARS4/CEN6 ori, Gent/ LEU2 Invitrogen  
    attR1, attR2, ccdB gene, Cm
R
; 
yeast two-hybrid vector    
bearing the GAL4 DNA binding  
domain 
 
pEXP
TM
32/Krev1  pDEST
TM
32 bearing Krev1 Gent/ LEU2 Invitrogen 
 
pEXP
TM
32/CKS2   pDEST
TM
32 bearing CKS2 Gent/ LEU2 This work 
 
pEXP
TM
32/CDK1 AF  pDEST
TM
32 bearing CDK1 AF Gent/ LEU2 This work 
 
pEXP
TM
32/CDK2 AF  pDEST
TM
32 bearing CDK2 AF Gent/ LEU2 This work 
 
pDEST
TM
22   PADH1, pUC ori, ARS4/CEN6 ori, Amp/ TRP1 Invitrogen  
    attR1, attR2, ccdB gene, Cm
R
; 
yeast two-hybrid vector    
bearing the GAL4 AD binding  
domain 
 
pEXP
TM
22/RalGDS-wt  pDEST
TM
22 bearing RalGDS-wt Amp/ TRP1 Invitrogen 
 
pEXP
TM
22/RalGDS-m1  pDEST
TM
22 bearing RalGDS-m1 Amp/ TRP1 Invitrogen 
 
pEXP
TM
22/RalGDS-m2  pDEST
TM
22 bearing RalGDS-m2 Amp/ TRP1 Invitrogen 
 
pEXP
TM
22/CKS2   pDEST
TM
22 bearing CKS2 Amp/ TRP1 This work 
 
pEXP
TM
22/CDK1 AF  pDEST
TM
22 bearing CDK1 AF Amp/ TRP1 This work 
 
pEXP
TM
22/CDK2 AF  pDEST
TM
22 bearing CDK2 AF Amp/ TRP1 This work 
 
 
 
Restriction enzymes  Recognition site   Buffer  Source 
AscI (10 000 U/ml)  5’…GGCGCGCC…3’  NEBuffer4 New England Biolabs 
    3’…CCGCGCGG…5’ 
 
NotI-HF (20 000 U/ml)  5’…GCGGCCGC…3’  NEBuffer4 New England Biolabs 
3’…CGCCGGCG…5’ 
 
SwaI (10 000 U/ml)  5’…ATTTAAAT…3’  NEBuffer3 New England Biolabs 
    3’…TAAATTTA…5’ 
 
Other enzymes         Source 
PfuUltra
TM
 II fusion HS DNA Polymerase      Stratagene 
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Antibiotics   Stock solution     Source 
Ampicillin   100 mg/ml     Bristol-Meyers Squibb 
Gentamicin   10 mg/ml     Merck 
Kanamycin   50 mg/ml     Sigma-Aldrich 
 
 
Commercial kits         Source  
ProQuest
TM
 Two-Hybrid System       Invitrogen 
pENTR
TM
 Directional TOPO
®
 Cloning Kits      Invitrogen 
Gateway
®
 Technology with Clonase
TM
 II      Invitrogen 
Wizard
®
 SV Gel and PCR Clean-Up System      Promega 
QIAquick PCR Purification Kit Protocol      QIAGEN 
Wizard
®
 Plus SV Minipreps DNA Purification System     Promega 
JetStar (Midi-prep)         Genomed 
  
 
Chemical/Reagent  Concentration     Source 
2-Log DNA Ladder (marker)  1000 μg/ml      New England Biolabs 
Adenine          Sigma-Aldrich 
Agarose, Type I          Sigma-Aldrich  
Bromophenol blue        Sigma-Aldrich 
Dithiothreitol (DTT)   1 M       Sigma-Aldrich 
dNTP mix    25 mM each dNTP     AB 
GelRed           Biotium 
Glyserol    99 %       Merck 
Histidine          Sigma-Aldrich 
Leucine          Sigma-Aldrich 
Nuclease-Free Water         Promega 
Uracil          Sigma-Aldrich 
 
 
 
 
 
